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Abstract 
Plants are an attractive host system for pharmaceutical protein production. Many 
therapeutic proteins have been produced and scaled up in plants at a low cost compared to 
the conventional microbial and animal based systems. The main technical challenge 
during this process is to produce sufficient level of proteins in plants. Low yield is 
generally caused by proteolytic degradation during expression and downstream 
processing of recombinant proteins. The yield of a human therapeutic protein interleukin 
(IL) -10 produced in transgenic tobacco leaves was found to be below the critical level, 
and is potentially due to degradation by tobacco cysteine proteases (CysPs). A total of 60 
putative CysP genes were identified in tobacco and based on their expression in the leaf 
tissue, 10 candidate CysPs (CysP1-CysP10) were selected for further characterization. 
The effects of silencing and overexpressing these CysPs on IL-10 accumulation were 
examined in tobacco. It was found that the recombinant protein yield in tobacco could be 
increased by stably silencing CysP6. Transient expression of CysP6 silencing construct 
also showed an increase in IL-10 accumulation in comparison to the controls. Moreover, 
CysP6 is localized to the Endoplasmic Reticulum (ER), suggesting that ER is the 
potential site of IL-10 degradation. Overall results suggest that CysP6 is involved in 
determining the yield of recombinant IL-10 in tobacco. 
Key Words 
Cysteine protease, tobacco, Interleukin-10, protein degradation, endoplasmic reticulum, 
silencing, ELISA  
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Chapter 1: Introduction 
1.1 Recombinant protein production systems 
Recombinant proteins are protein molecules such as vaccines, antibodies, 
enzymes, cytokines and hormones which are produced in a system other than the native 
biological hosts. Such proteins are widely used in prophylaxis or treatment of diseases, 
agricultural crop improvement and industrial applications. Recombinant therapeutics and 
neutraceutical proteins have a strong market demand and their production account for 
multi-billion dollar market volume in recent days (Durocher and Butler, 2009). 
Availability of the engineered bacterial strains and/or transgenic plants and animals has 
provided rapid advancement in large scale production of recombinant proteins. This 
advancement has resulted in increased accessibility to products that were not available or 
less safe to produce 20 years back. The impact of recombinant protein has been further 
extended by the development of industrial enzymes, diagnostic kits and biological control 
agents and continues to grow as applications in the field of detergent production and food 
processing have met with notable successes (Palomares et al., 2004).  
Recombinant proteins are produced in a variety of production systems ranging 
from prokaryotic systems such as bacteria to eukaryotic systems such as yeast, 
filamentous fungi, plants and animals. Escherichia coli and Bacillus subtillis are two 
widely used bacterial hosts for producing therapeutic proteins and industrial enzymes. A 
prominent therapeutic protein, human insulin, and a food processing enzyme, α-amylase, 
are produced in bacterial host system (Ma et al., 2003). Though well utilized for large 
scale production of many pharmaceutical proteins, bacterial systems are often 
disadvantageous because of the inability to synthesize and modify complex eukaryotic 
proteins. Proteins that require post-translational modifications (PTM) like glycosylation, 
carboxylation and phosphorylation cannot be processed in bacteria. PTM profoundly 
affects the biological activity of recombinant proteins and other properties relevant to 
their therapeutic application. Nearly 70% of the recombinant proteins that are in clinical 
trials at present, require glycosylation in their native form (Durocher and Butler, 2009). 
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In addition, recombinant proteins can be toxic to bacteria, form protein inclusion bodies 
during culture or get degraded by extracellular bacterial proteases.  
Animal cell cultures and yeasts are currently widely employed for the production 
of many complex proteins because of their ability to perform PTM. However, 
recombinant proteins produced from animal cell cultures are expensive and carry an 
inherent risk from contaminants of animal origin (Lienard et al., 2007). These 
contaminants include blood-borne pathogens such as animal viruses or prions and thus, 
the produced proteins require cautious downstream processing and quality control. 
Transgenic animals are also commonly used to produce recombinant proteins, which 
carry similar risks as cell culture systems. The risks from transgenic animal systems are 
generally due to recombinant proteins which originate from the sources such as milk, 
blood and egg white (Wang et al., 2013). Yeasts, on the other hand, have a potential of 
synthesizing large amounts of mature recombinant proteins. Being an eukaryote, yeasts 
are expected to have some advantages over bacteria. However, in many cases yeasts were 
shown to inappropriately fold and secrete monoclonal antibodies (Houdebine, 2009) and 
some yeasts did not glycosylate proteins or added sugars that were not found in native 
proteins (Hamilton et al., 2003).  
Transgenic plants are one of the most economical systems for the production of 
recombinant proteins of industrial and therapeutic use (Ma et al., 2003). In addition, 
plants have the ability to perform the majority of PTM’s required for correct folding and 
assembly of eukaryotic multimeric proteins. The process of transgenesis is relatively easy 
in plants and foreign proteins can be stored in leaves, root and seeds. With the abundant 
biomass, the amount of protein that can be produced in plant is virtually unlimited. 
Moreover, agriculture offers great flexibility for scaling up. Combined with these major 
qualities and with genetic tools available for continuous improvement, plants offer a 
unique and safer platform than any other existing host systems for recombinant protein 
production.   
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1.2 Recombinant protein expression in plants 
Plants are attractive biofactories for recombinant protein expression. They offer 
several advantages such as reduction in cost of production and increased scalability over 
microbial and mammalian cell culture systems. The low cost of large scale production is 
due to significant reduction in capital investment and running cost, as plants do not 
require huge fermenters as cell culture based systems or highly skilled personnel to 
operate them. It is estimated that recombinant proteins can be produced in plants at 2-
10% of the cost required to produce them in microbial systems and at 0.1% of the cost 
required to produce in animal cell cultures, although the cost of production may differ 
depending on the specific protein (Kusnadi et al., 1997). A comparative cost evaluation 
of producing monoclonal antibody Immunoglobulin (Ig) A in different host systems is 
shown in Figure 1.1. It was found that, producing purified IgA using either green plant 
biomass or grain significantly undercuts the cost of production using either animal cell 
culture or transgenic animals (Daniell et al., 2001).  
Recombinant proteins produced in plants are correctly assembled, functionally 
matured and glycosylated. Plants are capable of adding high-mannose type N-glycans, 
which are typical of mammalian glycoproteins (Cabanes-Macheteau et al., 1999; Bakker 
et al., 2001). Some concerns have been raised regarding PTM occurring in plants, 
especially immunogenicity caused by plant-specific glycosylations (Cabanes-Macheteau 
et al., 1999). However, remarkable achievements have been made in modifying plant-
specific glycans and removing enzymatic pathways which generate immunogenic 
residues on glycoproteins (Paccalet et al., 2007; Decker and Reski, 2008; Sourrouille et 
al., 2008; Strasser et al., 2008). Moreover, despite differences in N-glycan structures, 
antibodies produced in plants have shown similar stability and antigen binding capacity 
as their homologs produced in animal cells (Khoudi et al., 1999; Bouquin et al., 2002). 
Besides low cost of production and efficient PTM’s of recombinant proteins, other 
potential advantages offered by plants include reduced risk of contamination from 
animal-borne pathogens and high level production of proteins using improved molecular 
techniques that are easily adapted by plants (Kaldis et al., 2013).   
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Figure 1.1: Estimated cost of purified IgA antibody produced by different 
expression systems. The cost is plotted as a function of starting product concentration 
before recovery and purification. Costs for mammalian cell culture were derived from 
industry cost and purification facilities. Costs for transgenic goats were obtained from 
Genezyme Transgenics (Farmingham, MA, USA). Costs for plants compare green 
biomass (120.0 tonne ha
-1
) and seed production (7.5 tonne ha
-1
). Cost differences reflect 
mainly the different costs of production: the cost of purification and the extent of product 
loss during downstream processing were assumed to be the same for all systems. Adapted 
from Daniell et al., (2001).  
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Different plants have been used for recombinant protein production over the past 
two decades. This includes a wide range of food and non-food crops like tobacco, alfalfa, 
cereals (rice and maize), legumes (soybean) and fruits and vegetables (carrot, tomato, 
potato) (Ma et al., 2003). Tobacco (Nicotiana tabacum) is the most widely used plant 
host and has an established history in recombinant protein production. Being an easily 
available, non-food crop, tobacco offers a competitive edge over any other plant host in 
terms of large scale production. The primary advantage of tobacco is the presence of 
well-established genetic tools for transfer and expression of foreign genes. Furthermore, 
tobacco provides a high yield of protein per green leaf biomass, can be harvested 3-4 
times in a year and has a prolific seed production ability (Ma et al., 2003). Since tobacco 
is not a food or feed crop, the risk of food chain contamination via transgene escape is 
also limited. The first pharmaceutical protein produced in plant, human growth hormone 
(hGH), was expressed in the tobacco leaves (Barta et al., 1986). To increase the stability 
of hGH transcript and achieve an efficient translation into protein, the expression of hGH 
was driven by the promoter of NOPALINE SYNTHASE gene and polyadenylation sites 
were added to the hGH gene sequence. Since then, many recombinant proteins like 
monoclonal antibodies (IgG, IgA and IgM) and recombinant subunit vaccines (hepatitis 
B, E. coli enterotoxin and Cholera toxin B) have been successfully produced in tobacco 
and are in different stages of the clinical trials (Ma et al., 2003; Lienard et al., 2007). 
Other biopharmaceutical proteins produced in tobacco include plasma proteins, animal 
hormones and cytokines, which are used to improve blood and immune functions 
(Lienard et al., 2007). Some of the examples of such biopharmaceuticals are human 
albumin, erythropoietin and interleukins. As tobacco has been criticized for its high toxic 
alkaloid level, low alkaloid tobacco cultivar (cv. 81V9) has been established and can be 
efficiently used for production of recombinant proteins (Menassa et al., 2001). 
1.3 Stable and transient protein expression systems 
There are two main methods used for recombinant protein expression in plants: 
stable and transient transformations. Stable transformation of plants allows heritable 
integration of a transgene into the plant genetic material and consequently the acquired 
character is passed on to next generation. With transient transformation, the expression of 
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transgene is short-lived and the acquired trait is not transmissible to the next generation. 
Both strategies have been used widely for research and commercial production of 
recombinant proteins (Lienard et al., 2007). 
Stable protein expression can be achieved by transformation of nuclear and plastid 
(chloroplast) genomes. This strategy has been used for a great variety of plant species 
such as rice (He et al., 2011), potato (Scheller et al., 2001), tomato (Pan et al., 2008) and 
tobacco (Staub et al., 2000). Stable nuclear transformants can be generated by 
transformation using the gram-negative bacterium, Agrobacterium tumefaciens. Using 
well-established transformation protocols, exogenous DNA can be inserted into a Tumor 
inducing (Ti) plasmid of Agrobacterium and delivered into the plant tissues for 
production of the desired protein (McCormick et al., 1986; Lienard et al., 2007).  
Alternatively, metal particles coated with exogenous naked DNA can also be shot into the 
nuclear genome using a gene gun (Christou, 1995). Nuclear transformation allows for 
regeneration of transgenic lines, followed by extraction and purification of proteins from 
the transgenic tissues in multiple generations.        
Stable transformation of the chloroplast genome can be accomplished using the 
gene gun method. The advantages of chloroplast transformation include: a higher 
transgene copy number due to the presence of high number of chloroplast in 
photosynthetic cells and maternal inheritance of the chloroplast DNA which reduces risk 
of transgene escape via pollen. Furthermore, there is limited toxicity to the plant cell as 
proteins are produced and localized in the chloroplasts. In recent years, chloroplast 
transformation has been reported to result in a remarkable yield of heterologous proteins 
(Bock and Warzecha, 2010). However, chloroplasts are unable to perform typical 
eukaryotic PTM, such as protein glycosylation. With a limited protein maturation 
capacity, a chloroplast looks particularly well adapted for production of simple 
eukaryotic proteins (Jobling et al., 2003). Chloroplast transformation has been 
successfully attempted in very few plant species, primarily tobacco. 
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Transient expression of proteins in plants has been successfully performed using 
viral and non-viral expression vectors. Viral vectors are modified viral genomes which 
serve as a vehicle to carry foreign genes and the genes are expressed in plants as the by-
product of viral replication. Recombinant proteins that have been produced using 
classical plant virus expression systems utilize gene fusion with different viral coat 
proteins (CP), or replacement of CP genes with the gene of interest, and are transferred 
by viral infection to the plant (Kohl et al., 2006; Avesani et al., 2007). The second 
generation viral vectors utilize Agrobacterium for transferring a proviral replicon 
harbouring the gene of interest into the plant cells. The proviral replicon is constructed in 
the transfer (T) - DNA region of the Ti plasmid, which is then transferred into plant host 
such as Nicotiana benthamiana (Santi et al., 2006; Werner et al., 2011).  The protein is 
transiently expressed and harvested in approximately 2-14 days post-infiltration. Though 
considered ideal for expression of vaccine antigens, viral vector systems have biosafety 
issues regarding handling and use of virus originated material, and a cost disadvantage in 
comparison to the stable protein expression.  
     Non-viral expression vectors carrying a foreign gene of interest have also been used 
for transient expression of proteins in plants. It is commonly done by vacuum infiltration 
of recombinant Agrobacterium culture into the host plant (Vaquero et al., 1999). N. 
benthamiana is the most widely used host for this purpose, as its leaves are well suited 
for infiltration of the bacterial culture and results in transient transformation of many 
cells. A high level of protein can be transiently produced by large scale infiltration of N. 
benthamiana and commercially it has been brought to use by different companies 
(D'Aoust et al., 2008). However, using transient expression technique, higher yield of 
proteins are only achieved for a short period of time. In addition, low biomass of the plant 
hosts and lack of consistency between different batches of proteins are the major 
concerns in commercial production of recombinant proteins using transient expression 
systems. 
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1.4 Challenges of recombinant protein production in plants 
Recognized as an efficient and most economical system, plant bioreactors have 
emerged as a reliable source for recombinant protein production. However, plant 
bioreactors have two major concerns that limit the production of recombinant proteins. 
First, lower accumulation levels of the proteins of interest, and second, lack of the 
efficient protein purification methods. Recovery of proteins from plant biomass requires 
multistep purification using chromatography, adsorption, precipitation and filtration, and 
thus, is a delicate and costly process. In some cost analysis cases, it has been found that 
purification steps account for more of the costs than production in a plant host 
(Evangelista et al., 1998). However, pricing of the recombinant proteins is mostly 
dependent on total yield provided by the production systems and final accumulation of 
the proteins in their bioactive forms. Lower accumulation levels are generally observed, 
which is mainly due to the lower level of transgene expression and protein instability 
found during the expression and recovery of recombinant proteins.  
Transgene expression in plants is affected by various factors and involves 
regulation at different levels such as transcription, translation and post-translation. As a 
result, nascent and steady state transcript levels, translational turnovers, and the final 
levels of mature proteins do not co-relate to each other during recombinant protein 
production (Chen et al., 2013). Different strategies have been employed to improve 
transgene expressions in plants such as, using tissue specific promoters (Christensen and 
Quail, 1996), suppressing a commonly occurring transgene silencing (Lombardi et al., 
2009), intron induced splicing of transcript messenger (m)RNA (Vain et al., 1996) and 
modifying the 3’ and 5’ untranslated regions (UTR) of the gene for producing higher 
transcript levels (Strizhov et al., 1996). Using these approaches, significant improvements 
have been made in obtaining a higher recombinant protein yield, however, in many cases 
the levels of recombinant protein accumulation still remain low at <1% of the total 
soluble protein (TSP) (Doran, 2006). One of the major reasons for low yield is the 
degradation of foreign protein by plant proteases (Faye et al., 2005; Doran, 2006). 
Therefore, the low levels of protein accumulations result from a process of synthesis and 
degradation occurring during protein expression in different systems. 
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Protein degradations in the plant systems are known to occur by both intracellular 
and extracellular ways. Inside the cell, degradations can occur after synthesis, assembly 
and in some cases during PTM in the Endoplasmic Reticulum (ER) and Golgi apparatus. 
Outside the cell, proteins are degraded by extracellular proteases in the apoplastic space 
or in the culture medium when they are synthesized as secreted proteins (Hehle et al., 
2011). Protein fragments have been found to form in many plant hosts expressing 
recombinant proteins, such as in tobacco (De Neve et al., 1993; van Engelen et al., 1994; 
Schiermeyer et al., 2005), Arabidopsis (De Neve et al., 1993), corn (Russell, 1999; 
Russell et al., 2005), potato (Outchkourov et al., 2003) and alfalfa (Khoudi et al., 1999). 
The evidences for foreign protein degradation in these plants were obtained from Western 
blots using proteins present in the plant extracts. Cleavage products were also identified 
for proteins such as human growth hormone (Russell et al., 2005), plasminogen activator 
(Schiermeyer et al., 2005) and monoclonal antibody IgG1 (Sharp and Doran, 2001) using 
peptide sequencing methods. 
Since the yield of recombinant protein is severely affected by proteolytic 
degradation, there is a large interest in identifying and addressing the cause of 
proteolysis. Analyzing proteolysis events and characterizing protein fragments have 
revealed information regarding cleavage sites and mechanism of some recombinant 
protein degradation processes (Outchkourov et al., 2003). In one of the early studies, 
degradation of IgG1 monoclonal antibody in tobacco hairy root and suspended cell 
cultures was found to be caused by extracellular proteases (Sharp and Doran, 2001). 
Analysis of protein fragments by western blot suggested that IgG1 was degraded not 
during extraction but during synthesis and protein maturation along the secretory pathway 
of plant cell. Later, identification of a specific class of plant protease responsible for the 
proteolysis was successfully performed in many systems producing recombinant proteins. 
It was found that in planta degradation of MGR48 monoclonal antibody, an IgG1 type 
immunoglobulin from mouse, is catalyzed by acidic proteases in the apoplastic space 
(Stevens et al., 2000). The degradation was more prominent in older leaves than in 
younger leaves while a comparison was done by in-vitro incubation of recombinant IgG1 
with crude leaf extracts. This study indicated that the proteases associated with aging or 
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senescence, which also include the members of enzyme class cysteine proteases, are 
involved in IgG1 degradation. Cysteine proteases were also identified as the enzymes 
responsible for the degradation of recombinant sea anemone protein equistatin, during its 
expression in potato tubers (Outchkourov et al., 2003). More recently a rice cysteine 
protease, RETARDED PALEA1 (REP1), was also specifically found to degrade a human 
cytokine (human granulocyte macrophage-colony stimulating factor) while the protein 
was produced by secretion in rice cell suspension culture (Kim et al., 2008).  
1.5 Strategies in improving protein yield 
Although degradation of foreign protein in plants depend on different factors, it 
has been found that proteolysis occurs to a greater extent in tobacco than any other plant 
species such as Arabidopsis  (De Neve et al., 1993) and alfalfa (Khoudi et al., 1999). 
Since tobacco is used to produce many recombinant proteins, it is important to minimize 
the protein degradation to achieve high levels of functional proteins.  In whole tobacco 
plant, degradation of recombinant protein has been correlated to leaf maturation and 
senescence process (Stevens et al., 2000). Different strategies have been employed to 
influence the cell protease activity as a tool to improve the final protein yields. Targeting 
recombinant proteins to accumulate in the ER is one of the strategies used to minimize 
the exposure of proteins to cytosolic and apoplastic proteases (Menassa et al., 2001). 
Retention of proteins in the ER is helpful in their proper folding and maturation as ER 
harbours molecular chaperones and stabilizing agents. Strategies that directly affect 
protease activity have also been applied such as expressing companion protease 
inhibitior, which was successful in increasing the recombinant protein yield by 35-40% 
(Benchabane et al., 2009; Goulet et al., 2010). An efficient way to minimize protease 
activity was also suggested which involves identifying the responsible proteases and 
downregulating their expression that would allow for a sufficient accumulation of the 
target recombinant proteins (Kim et al., 2008). Alternatively, protease cleavage sites can 
also be identified and amino acids in the recombinant protein can be altered to minimize 
degradation. However, this approach first requires the identification of specific protease 
and cleavage sites in recombinant proteins, before the engineering of protease cleavage 
sites can be done. 
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In addition to reducing protein degradation, some other strategies have also been 
employed which are targeted to improve the recovery of recombinant proteins in plants. 
These strategies include: localization of proteins to a separable component such as to the 
embryo or oil bodies for an easier extraction, induction of protein bodies or secretion into 
cell suspension media for an easier purification, and production as fusion proteins to 
increasing the stability of the produced proteins (Gutierrez et al., 2013). Despite 
improvements in protein recovery such strategies often encounter problems; some of 
which have been reported during production of biopharmaceuticals as protein bodies or 
fusion proteins (Menassa et al., 2007; Kaldis et al., 2013). Biological inactivity of the 
fusion proteins were through animal feeding and cell lines functional assays.  
1.6 Plant proteases  
Plant proteases are a special class of enzymes involved in the degradation of 
native or foreign proteins. Plants contain four different class of proteases which are 
classified according to their catalytic site residues (van der Hoorn, 2008). These include: 
serine proteases, aspartic acid proteases, metalloproteases and cysteine proteases (CysPs). 
Serine proteases use the active site Ser as a nucleophile during catalytic reactions. With 
over 200 members among 14 families, serine proteases are the largest class of proteolytic 
enzymes in plants (van der Hoorn, 2008). The roles of serine proteases have been 
functionally characterized in proteolytic activation of enzymes (ABNORMAL LEAF 
SHAPE 1, ALE1 for the activation of the enzyme involved in embryogenesis in 
Arabidopsis), regulation of biosynthetic reactions (SINAPOYLGLUCOSE 
ACCUMULATOR 1 and 2, SNG1 and SNG2 in regulation of ester biosynthesis in 
Arabidopsis), as well as in tissue specific roles (STOMATAL DENSITY AND 
DISTRIBUTION 1, SDD1 for regulation of positional stomata development within leaf 
epidermis in Arabidopsis) (Lehfeldt et al., 2000; Tanaka et al., 2001; Von Groll et al., 
2002). 
Metalloproteases contain catalytic metal ions that activate water molecules for the 
proteolytic reactions. Over 100 plant metalloproteases have been identified which belong 
to the 19 different families (van der Hoorn, 2008). Metalloproteases are involved in 
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different aspects of plant growth and responses such as nodulation, plastid differentiation, 
regulation of shoot and root meristem size and thermo-tolerance (van der Hoorn, 2008). 
Aspartic acid proteases are also the other class of proteases that support water molecules 
for proteolysis. Two Asp residues are involved in binding to the water molecule which 
forms the active site in the enzyme. Aspartic acid proteases are the second most abundant 
plant proteases, with members divided into 3 large families (van der Hoorn, 2008). These 
proteases are similar to pepsin, their animal counterpart, and some of their members are 
involved in gametophyte survival and disease resistance signalling (e.g. Arabidopsis 
Promotion of cell survival-PCS1 and Constitutive disease resistance 1-CDR1) (Xia et al., 
2004; Ge et al., 2005).  
1.7 CysPs 
CysPs are ubiquitous proteins found in organisms ranging from bacteria, fungi, 
viruses to plants and animals. CysPs involve a cysteine sulfhydryl group in their catalytic 
reactions and their optimum catalytic activity is seen in a pH range of 4-6.5 (Grzonka et 
al., 2001). CysPs are involved in responses to many environmental and developmental 
cues and represent one of the thoroughly investigated protease class in plants. Till now, 
101 families of CysPs have been discovered which are listed in the MEROPS database 
and almost half of them are present in viruses (http://merops.sanger.ac.uk/cgi-
in/family_index?type=P#C). Many of these enzymes are found in bacteria (family C10, 
streptopain in Streptococcus pyogenes; family C25, gingipain R in Polyhyromonas 
gingivalis) and fungi (family C1B, bleomycin hydrolase in yeast). In mammals, two main 
groups of CysPs, calcium-dependent cytosolic calpains (family C2), and lysosomal 
cathepsins (family C1A like, subfamily cathepsin B, C, F, H, K, L, M, N, S, T, V and W) 
have been found and are known to maintain the homeostasis of the cell’s metabolism 
(Grzonka et al., 2001). Another representative CysP group in mammals are caspases 
(family C14), which play an important role in programmed cell death and hypersensitive 
responses controlling the so-called apoptosis cascades (Woltering, 2004).  
In plants, most of the CysPs discovered till date belong to the papain (C1A) and 
legumain (C13) families, but caspases and calpains have also been found in plants. In 
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addition, otubains (family C12) have also been found in plants whose roles are similar to 
their animal counterpart (Vierstra, 2003).  Among all these categories of CysPs, the 
papain family is the most widely characterized group and comprises of all peptidases 
which are structurally related to the protein, papain. The proteins in this family are 
recognized by the presence of two structural domains (Grzonka et al., 2001). As shown in 
Figure 1.2A, the catalytic pocket of papain is present in the cleft which is formed between 
the two domains. Figure 1.2B shows that, the substrate pocket of papain consists of at 
least 7 subsites which bind with 7 amino acid residues of the substrate for catalysis 
(Schechter and Berger, 2012). However, previous studies have concluded that only 5 
subsites of the enzyme (S1,S2,S3, S1’ and S2’) are necessary for substrate binding (Turk et 
al., 1998). The enzymatic activity of papain is dependent on the presence of a Cys, His 
and Asn residue, which form a catalytic triad of the enzyme. Asn in the catalytic triad is 
present as the conserved amino acid residue across all papain family CysPs and is 
important for the proper orientation of the His side chain (Beers et al., 2004).  It has been 
found that, the members of the papain CysPs preferentially cleave peptide bonds with 
Arg in P1 position or Phe at the P2 position, in a pH interval of 3.5-8 (Grudkowska and 
Zagdanska, 2004).  
The otubain (OTU) is the most recently characterized family of CysPs in plants. 
Little is known regarding the functional roles of plant otubains but they are thought to be 
involved in many ubiquitin-related cellular processes (Aquea et al., 2008). An otubain 
CysP, OTUBAIN-LIKE HISTONE DEUBIQUITINASE-1 in Arabidopsis, indicates its 
role in transcriptional repression via histone deubiquitination (Krichevsky et al., 2011). 
Otubain-like CysP was also discovered in pine and was found to be expressed during 
early somatic embryogenesis of pine trees, but its biological function remains unknown 
(Aquea et al., 2008). 
The main physiological role of CysPs is metabolic degradation of peptides and 
proteins. Mammalian CysPs have been associated with onset and development of many 
diseases that involve abnormal protein turnover (Twyman et al., 2003). In plants, CysPs 
play key roles in environmental stress response, nutrient remobilization and cellular 
housekeeping, which account for nearly 30% of the proteolytic activity in mature tissues 
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(Ueda et al., 2000). In Arabidopsis alone the genome codes for 32 papain-type CysPs, 
which are classified into eight main groups based on their function and sequence 
similarity to other known CysPs (Grudkowska and Zagdanska, 2004). These CysP groups 
include, senescence- and stress induced- aleurain, mammalian cathepsin B-like, pineapple 
bromelain-like, telo, KDEL and kiwi actinidain-like CysPs. The Arabidopsis CysPs are 
known to carry out multifarious roles in different tissues and at different stages of plant 
growth (Lee et al., 2004; Zhang et al., 2009). A highly senescence specific 
SENESCENSE-ASSOCIATED GENES-12 was identified in Arabidopsis, which was 
found to have an increasing expression during leaf senescence (Gan and Amasino, 1995). 
Three different KDEL-type CysP, C-TERMINALLY ENCODED PEPTIDE (CEP)-1, 2 
and 3 were also identified in Arabidopsis, and were found to be involved in the different 
stages of plant growth (Gietl and Schmid, 2001). It was suggested that CEP2 could be 
involved in developmental programmed cell death during the tracheary element 
differentiation and cell elongation processes in the tissues. CEP1 and CEP3 were 
expressed respectively in unpollinated ovules and mature siliques and represented 
increase in CysP activity during the different developmental stages of plant. Some CysPs 
in Arabidopsis have also been shown to be induced during biotic stresses. One of such 
example is RESPONSIVE TO DEHYDRATION (RD) 19, which was induced during 
infection with pathogenic bacteria Ralstona solanacearum, and was found to be involved 
in disease resistance against the pathogen (Bernoux et al., 2008).  
Though several CysPs have been characterized in Arabidopsis, not much is 
known regarding the role of CysPs in tobacco. NICOTIANA TABACUM CYSTEINE 
PROTEASE (NtCP) 23 is one of the earlier identified CysPs in tobacco and is involved 
in amino acid remobilization in senescing leaves (Ueda et al., 2000). Few other tobacco 
CysPs have also been characterized which are implicated in stress response, protein 
degradation during programmed cell death (Zhao et al., 2013) and pollen grain 
development (Zhang et al., 2009).   
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Figure 1.2 Structure and substrate binding sites of papain A) Papain has two 
structural domains with five alpha helices surrounding seven beta barrel sheets. The 
active site is present the cleft between the two domains and consists of the catalytic triad 
of Cys25, His159 and Asn175 residues (Grzonka et al., 2001). B) Substrate subsites of 
papain. The substrate pocket is approximately 25 Å in length. The Letters Sn and S’n 
represent subsites, where n=1, 2, 3, 4 and SH represents the sulfhydryl group. Pn 
represents individual amino acid residues of the substrate that binds with the respective 
subsites in papain (Schechter and Berger, 2012) 
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1.8 Interleukin-10  
Interleukin (IL)-10 is an immune-regulatory cytokine produced by immune cells 
such as T cells, natural killer cells and macrophages. The role of IL-10 has been 
investigated in the limitation and termination of immune responses during biological 
therapy of different malignant, autoimmune and chronic inflammatory diseases 
(Asadullah et al., 2003). IL-10 has been used as a model recombinant protein to study the 
factors that control the synthesis and accumulation of recombinant proteins in plants 
(Chen et al., 2013). For large scale production of IL-10, the low alkaloid variety of 
tobacco-cv. 81V9 has been previously used (Menassa et al., 2001). Recombinant IL-10 
was produced using stable expression in a higher amount than the transient expression 
and was found to be biologically active during murine assays (Menassa et al., 2007). To 
achieve higher levels of IL-10, subcellular targeting was utilized to accumulate IL-10 in 
the ER by fusing ER retention signal KDEL to its C-terminal end. However, the 
accumulation of IL-10 during initial stable expression is reported to be less than 1% of 
the total soluble protein, a level which is not sufficient for the viable commercial 
production of proteins. Some strategies have been applied to increase the yield of IL-10, 
mostly through the tobacco cell-culture based system (Kaldis et al., 2013). However, as 
stable protein expression can offers several advantages (as mentioned in section 1.3), 
improving IL-10 accumulation in the stable transgenic tobacco line can serve as a better 
source for production and supply of recombinant IL-10. 
1.9 Hypothesis 
Though tobacco allows high level production of recombinant proteins, 
accumulation of IL-10 was lower than the critical level of 1% of total soluble protein in 
stable tobacco lines.  Since CysPs are known to degrade heterologously expressed 
proteins in plants I hypothesize that tobacco CysP (s) affects IL-10 accumulation. 
Altering specific CysP gene product(s) can minimize proteolytic degradation of IL-10 
and increase its accumulation in tobacco leaves. 
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1.10 Objectives 
The whole genome sequence of tobacco is not available yet and only a few 
tobacco CysP sequences have been reported. However, the availability of an expressed 
sequence tag (EST) database of N. tabacum allows for the analysis of tobacco CysP 
sequences that have been deposited by the researchers worldwide 
(http://compbio.dfci.harvard.edu/cgi-bin/tgi/gimain.pl?gudb=tobacco). The database also 
provides information regarding tissue specific expressions of different CysPs sequences.  
The objectives of the present research are: 
• To identify all expressed CysP genes in tobacco.  
This will be addressed by an extensive search for CysP genes in the tobacco EST 
database and in silico analysis of predicted amino acid sequences for their domain 
information. 
• To select candidate CysP genes that may have an effect on IL-10 accumulation.  
Selection of CysPs will be done based on criteria such as expression in leaf tissue 
and availability of full length sequences in the database. Expression levels of 
candidate CysPs will be altered by RNAi silencing. The effect of RNAi silencing 
of candidate CysPs on IL-10 accumulation will be compared in silenced lines and 
controls.  
• To characterize IL-10 specific CysP gene(s).  
Transient silencing and overexpression of CysP will be done to study the results 
obtained from the stable CysP silenced lines. The potential site of IL-10 
degradation will be studied by subcellular localization of candidate CysPs. 
Because IL-10 was targeted to the ER, it is imperative to check the localization of 
candidate CysP potential of degrading IL-10.  
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Chapter 2: Materials and Methods 
2.1 Plant materials and growth conditions 
Seeds of tobacco (N. tabacum) cv. 81V9 and the transgenic line G7 (hereby called 
as IL-10 control) were obtained from Dr. Rima Menassa (Agriculture and Agri-Food 
Canada, London). The IL-10 control tobacco line overexpresses IL-10  and accumulates 
in the ER (Menassa et al., 2001). The tobacco seeds were grown under sterile condition in 
magenta boxes at 24°C and 16 h daylight for leaf disc transformation. For sterilization, 
seeds were treated with 70% ethanol for 30 sec and air dried. Seeds were sown on 
Murashige and Skoog (MS) basal medium (PhytoTechnology Laboratories, USA), 
supplemented with 1% (w/v) phytoagar (PhytoTechnology Laboratories, USA), 4% (w/v) 
sucrose (Sigma-Aldrich, Germany), phytohormones and the antibiotic, kanamycin (50 
µg/ mL).  
Transgenic tobacco plants were grown on PRO-MIX BX MYCORRHIZAE
TM 
soil 
(Rivière-du-Loup, Canada) at 24°C, 60% relative humidity and 16 h daylight in the 
greenhouse. For N. benthamiana, seeds were sprinkled into wet PRO-MIX BX 
MYCORRHIZAE
TM
 soil (Rivière-du-Loup, Canada) and pots were covered with a 
transparent plastic cover and grown at 25°C/ (day/night), 50% humidity and 16 h daylight 
in the growth chamber. Two-week-old seedlings were transferred to new pots and 
watered regularly. A nutrient mixture of nitrogen, phosphorus, and potassium (20-20-20) 
was applied once a week for both types of tobacco plants grown in growth chamber and 
greenhouse. 
2.2 Bacterial strains 
E. coli DH5α and DB3.1 strains (Invitrogen, USA) were used for cloning 
purposes. For stable transformation in tobacco and transient infiltration in N. 
benthamiana, Agrobacterium strain GV3101 was used. All bacterial transformations were 
carried out by electroporation in a Gene Pulser® Cuvette (Bio-Rad Laboratories, Inc., 
USA) using MicroPulserTM (Bio-Rad Laboratories, Inc., USA). The electroporation was 
19 
 
done for 6 millisec at an output voltage of 1.79 kV and 2.18 kV for DH5α and GV3101 
respectively. 
`2.3 In silico analysis 
To identify CysP genes present in tobacco, the DFCI tobacco gene index 
(http://compbio.dfci.harvard.edu/cgi-bin/tgi/gimain.pl?gudb=tobacco) was searched using 
‘cysteine protease’ as keyword. This database contains ESTs obtained from cDNA 
libraries constructed using different tissues or plants grown under different conditions or 
exposed to different stresses. Complete and partial sequence availability of all putative 
CysPs was checked using ExPASy software (http://web.expasy.org/translate/). Candidate 
genes were selected according to their tissue-specific expression and availability of 
complete sequences in the EST database. Predicted amino acid sequences of candidate 
CysPs were aligned using CLUSTALW and the alignment file was exported to 
BOXSHADE 3.21. The domain organizations of candidate CysPs were predicted using 
Pfam 27.0 (http://pfam.xfam.org/). The subcellular localization of putative CysPs was 
predicted using PSORT program (http://psort.hgc.jp/form.html). 
2.4 Cloning  
To clone CysP genes from tobacco, candidate genes were amplified by 
polymerase chain reaction (PCR) using leaf cDNA as template and gene specific primers 
which contained attB recombination sites. Primers and PCR conditions used for 
amplifying CysP gene fragments for silencing and full open reading frames for 
overexpression are shown in Table 2.1. All the primers contain th attB1 adaptor sequence 
(5’-GGGG ACA AGT TTG TAC AAA AAA GCA GGC T-3’ for forward primers) and 
the attB2 adapter sequence (5’-GGGG AC CAC TTT GTA CAA GAA AGC TGG GT-3’ 
for reverse primers), preceding their 5’sequences for cloning in gateway vectors.  
2.4.1 Cloning for silencing constructs 
To create CysP silencing constructs, a gene-specific region (178-345 base pairs) 
for each candidate CysP was selected and amplified using gene-specific primers (Table 
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2.1). The PCR products were separated on 1.5% agarose gels. A single band of CysP 
amplicon was excised from the gel and purified using EZ-10 Spin Column DNA Gel 
Extraction Kit (Bio Basic Inc., Canada). The purified gene fragments were recombined 
into gateway entry vector pDONR/Zeo using the BP clonase reaction mix (Invitrogen, 
USA), and the BP reaction products were transformed into E. coli DH5α by 
electroporation. The transformed cells were grown in low salt Lysogeny Broth (LB) agar 
containing 50 µg/mL of zeocin. Colonies that contained the recombinant plasmid 
(pDONRZ-CysP) were screened using CysP gene specific primers. The positive E. coli 
colonies that contained recombinant plasmid were picked and grown overnight in 3 mL 
of LB at 37
0
C. Plasmid DNA was extracted from overnight culture using EZ-10 Spin 
Column Plasmid DNA Kit (Bio Basic Inc., Canada). The presence of CysP sequences in 
the recombinant plasmids was verified by sequencing using vector-specific M13 forward 
and reverse primers. After sequence verification, the pDONRZ-CysP plasmids were 
recombined into RNAi destination vector pB7GWIWG2(II),0 or pK7GWIWG2D(II),0 
using the LR clonase reaction mix (Invitrogen, USA). The destination vector 
pB7GWIWG2(II),0 contains spectinomycin resistance gene for selection in bacteria, and 
a Bar gene which confers herbicide BASTA resistance for the selection of transformed 
plant cells (Figure 2.1A). Vector pK7GWIWG2.D contains kanamycin resistance for 
selection in bacteria and an enhanced green fluorescent protein (eGFP) reporter gene, 
which was used for visual screening of transgenic plants using UV fluorescent 
microscope (Figure 2.1B).  
The LR reaction products were transformed into E.coli DH5α by electroporation 
and plated on a LB agar plate containing 50 µg/mL spectinomycin. A schematic 
representation of BP and LR recombination is shown in figure 2.2A. After LR 
recombination, positive E.coli colonies were screened using colony PCR with the primer 
combination as shown in Figure 2.2B. The CysP fragments were inserted in the opposite 
orientation after recombination with the destination vector. The orientation of each 
candidate CysP gene in the destination vector was confirmed using a gene-specific 
forward primer (CysPF) and the outward chloramphenicol resistance (Cmr) forward and 
reverse primers (CmrF: 5’- CGA TTC AGG TTC ATC ATG CCG TCT-3’  and CmrR: 
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5’-TGA GCA ACT GAC TGA AAT GCC TCC-3’). Positive E.coli colonies that 
contained recombinant pK7GWIWG2D(II),0-CysP or pB7GWIWG2(II),0-CysP plasmids 
were picked and grown overnight in 3 mL of LB at 37 
0
C. Plasmids DNA were extracted 
from the overnight culture using EZ-10 Spin Column Plasmid DNA Kit.  For the purpose 
of introducing recombinant pK7GWIWG2D(II),0-CysP and pB7GWIWG2(II),0-CysP 
plasmids into tobacco, the plasmids were transformed into Agrobacterium using 
electroporation and grown in LB agar containing rifampicin (10 µg/mL), gentamycin (50 
µg/mL ) and kanamycin (50 µg/mL for pK7GWIWG2D(II),0-CysP plasmids) or  
spectonomycin (50 µg/mL for pB7GWIWG2(II),0-CysP plasmids).     
 2.4.2 Cloning of CysP genes for overexpression  
To identify CysP genes that act on factor (s) which directly or indirectly influence 
IL-10 accumulation, full-length coding regions of CysP genes were amplified using gene 
specific primers (Table 2.1), purified using EZ-10 Spin Column DNA Gel Extraction Kit 
(Bio Basic Inc., Canada) and recombined into pDONR/Zeo vector as described in section 
2.4.1. Colonies that contain the pDONRZ-CysP plasmids were screened by PCR using 
gene specific primers. Positive colonies that contained the right size of full length CysP 
insert were selected and cultured overnight at 37
0
C in LB medium containing zeocin (50 
µg/mL). Plasmid preparation was done from the overnight culture using the EZ-10 Spin 
Column Plasmid DNA Kit (Bio Basic Inc., Canada) and sequences were verified. After 
sequence verification recombinant pDONRZ-CysP plasmids were recombined with 
overexpression vector pB7WG2D,1 using the LR Clonase reaction mix and transformed 
into E.coli DH5α (Invitrogen, USA). This destination vector contains a cauliflower 
mosaic virus 35S promoter, which drives constitutive expression of CysP genes in the 
plant and Bar gene for selection of transformed plant cells (Figure 2.1C). E.coli colonies 
containing the recombinant plasmids (pB7WG2D,1-CysP) were screened using gene 
specific primers by PCR. Positive colonies were cultured overnight at 37
0
C in LB 
medium containing spectinomycin (50 µg/mL).   
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Table 2.1: List of primers used for silencing and overexpression of CysPs.  
Primer name Sequence (5'-3') 
Primer 
annealing 
temperature 
(0C) 
Amplicon 
size (base 
pairs) 
Silencing 
Primers 
  
 
CysP1F CCA CCA TAA ACA ATC ATC CAA TCC GT 52 280 
CysP1-5R TAC CTC TTC CCA TAC CTG TGA GC 
 
 
CysP2F TCC GTA CTT TTC TAG GAG CTT CAC  52 242 
CysP2R TGA CTA GTG TCA CAG TCG ACA AG 
 
 
CysP3F CAA CTC ATA GCT CCA CTC TCA CCA  52 178 
CysP3R TCC ATG TTC GAG TAG CCA TGA CTC  
 
 
CysP4F GGC TAG CTA GTG GTT CAT AAT GGC  60 280 
CysP4R CCA CGC CGA GTT TAT ACC CTT  
 
 
CysP5F ATC CCT TCC CCA CAT TCT CTG A 52 249 
CysP6F1 GCG ATA CTT CCT ACA ATG ACG GTT G 54 345 
CysP6R1 CAT CTC ACT ACC ATA TCC ACA GCA TCA 
 
 
CysP7F1 CGT GGG ATA CTC TTC AGA TGA CTT GAC 52 204 
CysP7R1 TCA GCA AAC TCA TTT AGA CCA AGC C 
 
 
CysP8F1 GAA TGG AAA CAG AAG CAG GGG AAA G  53 281 
CysP8R1 GGA GGA GCA TCA CAA TAA ACT GGA G 
 
 
CysP 9F GCA TGT GGC TGA TGC AGG A 50 255 
CysP 9R CGT GTT CTT CTA AGG GCA 
 
 
CysP10F1 GTC CGT AAA ACC CAA AAC CAC AC 52 382 
CysP10R1 GCT TCT CCA TCT CTC ATA CAA CTC C 
 
 
 
Overexpression 
Primers 
  
 
CysP1-OE-F ATG TCT CGT TTC TCA CTC CTA TTG GC 51 1080 
CysP1-OE-R GAA CGG AGC CCG AAT GCT GTT GTA 
 
 
CysP2-OE-F CGA GGA GCC TTG ACG AGA AAG ACA A 52 947 
CysP2-OE-R CTT AGA GTT CAT CCT TAG GTG CCG T 
 
 
CysP5-OE-F GTT CCA ATG TCT CGT TTC ACA CTC C 52 1087 
CysP5-OE-R AGG CAA CGA CAG GGT AGG AT 
 
 
CysP6-OE-F GGC ATG GCA ACT CTT AGC TTT ACT C 52 1401 
CysP6-OE-R TCA AGA ACT GCT CTT CTT TCC TCC    
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Figure 2.1:  Gateway silencing and overexpression vectors for use in plants. A) 
RNAi silencing vector, pB7GWIWG2(II),0, B) RNAi silencing vector, 
pK7GWIWG2D(II),0 and C) Overexpression vector, pB7WG2D,1. All the vectors 
contain attR sites and a ccdb casettee for selection of successful recombination events. 
Vector maps adapted and modified from: http://gateway.psb.ugent.be/search 
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Figure 2.2: Cloning and screening strategy for CysP gene silencing. a) Schematic 
illustration of gateway cloning for silencing of tobacco CysP genes. CysP PCR products 
were cloned into entry vector pDONR/Zeo by BP recombination and RNAi silencing 
vector pB7GWIWG(II),0 or pK7GWIWG2D(II),0 by LR recombination. CysP gene 
fragments are placed in the opposite orientation after recombination event in the silencing 
vector. b) Screening strategy for CysP gene inserts in RNAi vector. Gene specific 
forward primer (CysPF) and chloramphenicol resistance forward and reverse primers 
(CmrF and CmrR) are used to screen the double inserts of CysPs. 
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Plasmid preparation was done from the overnight culture using EZ-10 Spin Column 
Plasmid DNA Kit and transformed into Agrobacterium followed by plating in LB agar 
containing rifampicin (10 µg/mL), gentamycin (50µg/mL) and   spectinomycin (50 
µg/mL).  The Agrobacteria containing overexpression constructs were used for transient 
infiltration in tobacco plants.  
2.4.3 Cloning for subcellular localization 
To study the localization of a candidate CysP, translational fusion was created 
with a yellow fluorescent protein (YFP) using the gateway cloning method. Full-length 
CysP6 excluding the stop codon was amplified by PCR and recombined to a gateway 
entry vector pDONR/Zeo by the BP reaction (Invitrogen, USA). The reaction was used to 
transform E.coli DH5α by electroporation and positive clones were screened using gene-
specific primers. Recombinant pDONRZ-CP6 plasmid was extracted from an overnight 
culture grown in a 3 mL LB containing kanamycin (50 µg/ml) at 37
0
C. The pDONRZ-
CysP6 construct was sequenced using CysP6 sequencing primers and recombined with 
the destination vector pEarlyGate101 to create a CysP6-YFP fusion using LR clonase. 
The LR reaction product was transformed into E.coli DH5α using electroporation and 
plated on the LB agar containing 50 µg/mL kanamycin, followed by screening using 
CysP6 gene-specific primers. A positive E.coli colony containing recombinant plasmid 
pEG101-CysP6-YFP plasmid was picked and grown overnight in a 3 mL LB at 37
0
C. 
Recombinant plasmid was extracted using EZ-10 Spin Column Plasmid DNA Kit and 
transformed into Agrobacterium by electroporation.  
A cyan fluorescent protein (CFP) targeted to localize in the ER was used as a 
control to verify the probable localization of CP6-YFP in the ER. The control construct 
was obtained from Arabidopsis Biological Resource Center (ABRC, clone name: ER-
CK) and contains an ER retention signal sequence fused to C-terminal region of CFP 
(Nelson et al., 2007). 
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2.5 Tobacco transformations 
2.5.1 Stable transformation and generation of transgenic lines 
To generate stable tobacco transgenic lines, the CysP silencing constructs were 
introduced into leaf cells by Agrobacterium mediated transformation. Agrobacterium 
with CysP silencing construct (as obtained in section 2.4.1) was grown in 3 mL of 
infiltration culture medium containing 10 mM morpholino-ethanesulfonic acid [MES] pH 
5.6, 100 μM acetosyringone supplemented with rifampicin (10 µg/mL), gentamycin (50 
µg/mL) and kanamycin (50 µg/mL for pK7GWIWG2D(II),0-CysP) and  spectinomycin 
(50 µg/mL for pB7GWIWG2(II),0-CysP ). The 3 mL culture was grown overnight at 28 
0
C and transferred to a fresh 40 mL infiltration culture medium later. The culture was 
allowed to grow at 28 
0
C until it reached an optical density (OD600) of 0.5-0.8. After the 
optimum OD was obtained, the culture was transferred to a 50 mL conical tube and 
centrifuged at 3000g for 30 min. The pellet was resuspended in Gamborg’s solution (3.2 
g/L Gamborg’s B5 and vitamins, 20 g/L sucrose, 10 mM MES pH 5.6, and 200 μM 
acetosyringone) to a final OD600 of 1 and incubated at room temperature for 2h with 
gentle agitation to activate the virulence gene required for transformation. 
Transformation of tobacco leaves was performed using the leaf disc 
transformation method in a sterile laminar flow hood. Five mm
2 
tobacco leaf explants 
were submerged in Agrobacterium suspensions, briefly dried on a filter paper, and placed 
on plates containing MS medium supplemented with naphthalene acetic acid (NAA- 1 
mg/L) and benzyl aminopurine (98 μg/L) (MST-agar medium). After 2-3 days of co-
culture with Agrobacterium, the leaf explants were transferred to a new MST-agar 
medium containing Timentin (500 mg/L) and BASTA (4 mg/L). Timentin helps to kill 
live Agrobacterium cells after the transformation. The explants were then transferred to a 
BASTA only MST medium after 3 days and the medium was changed every week until 
calli developed from the transformed plant cells. The regenerated calli differentiated into 
independent shoots, which were cut and transferred to a rooting MST-agar medium after 
6 weeks. The rooting medium was supplemented with NAA (1 mg/L) only. CysP 
silenced shoots were transferred to the soil after sufficient roots were grown in the 
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rooting medium. Individual lines were grown in different pots and transferred to the 
greenhouse. The plants were grown together with IL-10 control plants and used for the 
evaluation of IL-10 levels.   
2.5.2 Transient expression 
To study the subcellular localization of CysP6 and the effect of overexpressing 
some CysPs on IL-10 accumulation, transient transformation was used. For the 
subcellular localization study, 4-6 weeks old tobacco leaves (tobacco, in this case means 
N. benthamiana) were infiltrated with the transformed Agrobacterium suspension culture 
as described in the section 2.5.1. For co-localization with the ER control, Agrobacterium 
cultures containing pEG101-CP6-YFP and pEG101-ERCFP constructs were mixed in a 
ratio of 1:1 and co-infiltrated in the tobacco leaves. Infiltration was done using a 1 mL 
needle-less syringe by pressing the plunger against the lower leaf epidermis. The plant 
was left at room temperature and the subcellular localization was visualized after 48 h 
using confocal microscopy. 
For the transient overexpression of CysPs, Agrobacterium cells containing the 
CysP overexpression constructs were infiltrated into tobacco, as described in section 
2.5.1 for the transfer of transgenes into plant, and with the help of needle-less syringes. 
The tissues were collected 4 days post infiltration in order to analyze the effects on IL-10 
accumulation levels.     
2.6 Confocal Microscopy 
Transient expression of CP6-YFP and CFP-KDEL was visualized using a Leica 
TCS SP2 inverted microscope. A 63X water immersion objective lens was used at an 
excitation wavelength of 514 nm for YFP and 434 nm for CFP. The emission 
wavelengths for YFP and CFP were between 530-560 nm and 460-490 nm, respectively.  
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2.7 Sample collection for protein and RNA extractions 
Leaf tissues were sampled when tobacco plants reached a height of ~1.5 ft. Six to 
eight leaf discs were taken from the 3
rd,
 4
th
 and 5
th 
leaves from the top. Leaf tissues were 
collected in 2 mL Eppendorf tubes that contained 2 small copper beads (BioSpec 
Products Inc, USA). Once the leaf samples were collected and the weight recorded, they 
were immediately frozen in liquid N2 and stored at -80 
0
C freezer.  
2.8 Protein extraction 
  For protein extraction, tubes containing leaf samples were placed in precooled 
homogenization blocks, and homogenized using a mixer mill at 25 Hertz for 1 min. 
Protein extraction buffer (400 µL) containing 1X Phosphate buffer saline (PBS, pH 7.4), 
0.1% TWEEN-20, 1mM EDTA, 100 mM sodium ascorbate, 2% PVPP, 1 mM PMSF and 
100 µg leupeptin was added to the homogenized tissue. PVPP is insoluble in water, hence 
required at least 2-4 h of hydration before use. The lysates were centrifuged at 14,000 g at 
4
0
C for 10 min in a microcentrifuge, and the supernatants were collected.  
2.9 Protein assay 
Total soluble protein was measured using the Bradford dye reagent (Bio-Rad 
Laboratories, Inc., USA). Protein assays were carried out according to Bradford’s method 
(Bradford, 1976). Bovine serum albumin (BSA) solutions of concentrations 0, 40, 100, 
200, 400, 600 and 800 µg/mL were used for creating a standard curve.  Standards and the 
TSP samples (10 µL each) were added to a 96-well plate, and 200 µL of Bradford dye 
(diluted 1:5 in ultrapure water) was added to each sample. The absorbance was measured 
at 595 nm after 30 sec using a BioTek Synergy2 microplate reader (BioTek Instruments, 
Inc., USA). Three technical replicates were used for each sample and standard. The 
absorbance of the BSA standards was plotted against their concentrations to generate a 
standard curve whose linear range was used to determine the concentrations of proteins in 
unknown samples. The extraction buffer was used as blank to subtract the background.  
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2.10 Enzyme-linked immunosorbent assay (ELISA) 
To measure IL-10 levels in CysP silenced and overexpressed tobacco lines, 
ELISA was used. An enhanced protein binding ELISA plate (Nunc-Immuno, Maxi-Sorp 
plates, VWR International, USA) was coated with 100 ng of purified rat anti-human IL-
10 capture antibody per well and incubated at 4
0
C overnight. The antibody was diluted in 
in 0.1 M Na2HPO4 pH 9.0. Following the incubation, the plate was washed two to three 
times with wash buffer (PBS and 0.05% (v/v) Tween-20) and saturated with 200 µL of 
blocking buffer (1% BSA in PBS) to avoid non-specific binding in the wells.  
The extracted protein samples were diluted by 10 times in the blocking buffer and 
100 µL of diluted samples were added to each well of the capture antibody-coated ELISA 
plate. Pure protein for human IL-10 (BD Pharmingen, Canada) was used as the standard 
at the concentrations of 2, 1, 0.5, 0.25, 0.125 and 0.0625 ng/mL.  Once the standards (10 
µL) and samples were loaded, the plate was incubated at room temperature for 4 h and 
then washed two to three times with the wash buffer. Three technical replicates were used 
for all samples and standards. Following the wash, biotinylated anti-IL-10 antibody (BD 
Pharmingen, Canada, 100 ng/well; 100 µl of 0.5 µg/ml diluted antibody solution in 
blocking buffer) was added to each well using multichannel pipette. The plate was 
incubated for 1 h at room temperature with gentle shaking, followed by three washes with 
the wash buffer. After the wash, secondary antibody conjugated to Horse Radish 
Peroxidase (HRP) (BD Pharmingen, Canada, 100 ng/well diluted in blocking buffer) was 
added to each well.  The plate was kept at room temperature for 30 min followed by four 
washes with the wash buffer before adding the substrate. Hundred microliter of 2,2'-
azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS dissolved in 300 ng/mL of 
0.1M citric acid) containing 30% H2O2 was added to each well, incubated at room 
temperature for 3.5 min, and the absorbance was measured at 405 nm using microplate 
reader (Bio TeK Instruments, Inc., USA). The absorbance of blocking buffer was used as 
blank. IL-10 standard curve was generated by plotting absorbances of the standards 
against their respective concentration and the graph was used to determine IL-10 level in 
the unknown samples.  
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2.11 Genomic DNA extraction and genotyping of T1 transgenic lines 
To screen transgenic lines, T1 seeds obtained from the CysP silenced T0 tobacco 
lines were grown in MST-agar containing BASTA (4 mg/L). The BASTA resistant 
seedlings were transferred to small pots. Seedlings were grown for 2 weeks and leaf 
tissue was sampled from each independent transgenic line for genomic DNA extraction.  
Genomic DNA was extracted from tobacco leaves using the cetyl-
trimethylammonium bromide (CTAB) method  (Stewart and Via, 1993).  Approximately 
5 to 8 leaf discs were lysed in a 2 mL microfuge tube using 500 μL of extraction buffer 
(1.4 M NaCl, 2% [w/v] CTAB, 50 mM Tris-HCl pH 8.0, 10 mM EDTA and 0.1 mg/mL 
RNase added just prior to use) and incubated at 65
0
C for 20 min. The samples were 
allowed to cool down to room temperature and 500 μL of chloroform was added. The 
mixtures were vortexed thoroughly and centrifuged for 3 min at 14000 g. The aqueous 
upper phase was transferred to a clean microfuge tube to which 0.6 volume of 
isopropanol was added and mixed thoroughly by vortexing. The samples were then 
centrifuged for 10 min at 14000 g, and the pellets washed with 1 mL 70% (w/v) ethanol. 
The pellets were air dried and dissolved in 20-50 μL of sterile MilliQ water. 
Genotyping was carried out to identify transgenic T1 plants using genomic DNA 
as template and chloramphenicol resistance primers CmrFw: 5’-
GGAGGCATTTCAGTCAGTTGCTCA- 3’ and CmrRv: 5’-
AGACGGCATGATGAACCTGAATCG-3’ (Figure 2.1A).  
2.12 RNA isolation and RT-PCR analysis 
To check silencing or overexpression of CysPs in tobacco, total RNA was 
extracted from tobacco leaves using a RNeasy Plant Minikit (Qiagen Inc., USA) 
following manufacturer’s instructions  with slight modifications. On column DNase1 
(RQ1 RNase-Free DNase, Promega, USA) digestion was performed in order to get rid of 
the any genomic DNA contamination during extraction. RNA was quantified using a 
NanoDrop spectrophotometer (Thermo SCIENTIFIC, USA). The integrity of RNA was 
checked by running 300-500 ng of RNA on 1.2% (w/v) agarose gel in 1X TAE buffer (40 
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mM Tris, 40 mM acetate, 1 mM EDTA, pH 8.2). cDNA was synthesized from 1 μg of 
RNA using a QuantiTect® Reverse transcription Kit (Qiagen Inc., USA). To check the 
transcript level of CysP6 in transient silencing or overexpression experiments, gene 
specific primers (Table 2.1, CysP6-OE-F/R) were used for 36 cycles of PCR. Ten 
microliters of amplified product was run on a 1.5% agarose gel. 
A quantitative RT-PCR (qRT-PCR) was performed to evaluate the level of CysP6 
in T1 stable CysP6 silenced plants. For this procedure, SsoFastTM EvaGreen® Supermix 
(Bio-Rad Laboratories, Inc., USA) was used with CFX96 real-time PCR detection system 
(Bio-Rad Laboratories, Inc., USA). CysP6 transcript accumulation was checked using the 
following primers, qCP6F: 5’- CACCATATCCCTACTTCTCCTCCTC -3’ and qCP6R: 
5’- CCATGTTCGACTAGCCATGACTC-3’. The amplicon was cloned into pGEMT 
vector (Promega, USA) and its sequence was verified. N. tabacum Actin (NtActin, Gene 
bank ID: AB158612.1) was used as a reference gene. The primers used for reference gene 
amplification were, qNTActinF: 5’-GGTTGGTATGGGTCAAAAGGATCA-3’ and 
qNTActinR: 5’-GGAGCAACACGCAACTCATTG-3’. The melting curve analysis was 
performed with pDONR-CysP6 plasmid as a template. 
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Chapter 3: Results 
3.1 Tobacco genome contains at least 60 putative CysPs 
To identify CysP genes in tobacco, an in silico search was done using the DFCI 
tobacco gene index (TGI) database. The TGI consists of 324,058 ESTs. A total of 55 
putative CysP genes were identified by the keyword search ‘cysteine protease’. Out of 55 
putative CysP gene sequences, 32 were tentative contig sequences which were created by 
assembling ESTs into virtual transcripts. The rest were 23 singleton sequences, each of 
which represented a unique EST in the database. These putative CysPs were derived from 
tobacco cDNA libraries constructed from a variety of tissues including leaf, flower, root, 
whole seeding or cultured tobacco (cv Bright Yellow, BY-2) cells. Table 3.1 provides a 
list of putative CysP genes as represented by their tentative contig or singleton sequence 
identification numbers, tissue specific expressions and predicted protein sizes for those 
where complete coding regions were available. Of the 55 putative CysP genes, 10 genes 
were selected as candidates for further study based on complete sequence availability and 
expression in leaf tissue. Leaf specific CysPs were of main interest, as the principal 
objective of this research was to identify potential CysPs involved in determining IL-10 
yield in leaf. The candidate CysPs were named as CysP1 to CysP10.  
In addition to the 55 putative CysPs identified through a database search, five other 
CysP sequences were found through a literature search. Their accession numbers and the 
paralog tentative contig sequences are shown in Table 3.2. Among them, NtCP1 was 
expressed only in senescing leaves and NtCP2 was expressed in mature tobacco leaves. 
NtCP56 was strongly expressed in anthers. CyP7 and CyP8 were expressed in leaf 
tissues. A very high degree of amino acid identity was found between NtCP56 and 
CysP10 (99.17%), which indicates that they might perform similar functions in tobacco. 
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Table 3.1 List of putative CysP genes in tobacco. 
TC 
sequence 
Most 
expressed 
ina 
Candidate 
CysP 
Predicted 
Protein 
size (AA)b 
Singleton 
Sequence 
Most 
expressed 
in 
Predicted 
Protein 
size (AA)b 
TC122594 R,L 
CysP1 
(NtCP23) 
360 BP132783 BY-2 _ 
TC123875 R 
 
_ BP529990 BY-2 _ 
TC124565 L,F,R CysP2 240 CN498801 L _ 
TC124614 R,L 
 
_ DV159633 Seed _ 
TC124631 L,F,R 
 
_ DW001815 L,R _ 
TC126531 L,F,R CysP3 _ AM837057 L _ 
TC128311  L,F,R 
 
_ AM829003 L _ 
TC129167 L,F,R 
 
_ AM831937 L _ 
TC129618 L,F,R, BY-2 CysP5 360 AM791536 L _ 
TC130400 R 
 
_ AM787277 L _ 
TC130996 L,F,R 
 
_ AM846161 W _ 
TC132948 L,F,R CysP6 (NtCP6) 466 AM834885 W _ 
TC133645 L,F,R CysP4 349 AM836936 W _ 
TC133786 BY-2 
 
_ AM801664 L _ 
TC135985 L,R 
 
_ AM787303 W _ 
TC139681 L,F,R 
 
_ AM823454 W _ 
TC140530 L,R,W 
 
_ AM801795 W _ 
TC141516 L,F,R CysP7 355 AM844688 W _ 
TC143494 L,F,R CysP8 434 FG634183 L _ 
TC143787 L,F,R CysP9 301 FG644916 L _ 
TC144748 L, R,W 
 
_ FG167001 R _ 
TC145665  L,R 
 
_ FG172560 R _ 
TC151953 W 
 
_ FG190220 L,F,R _ 
TC152484 L,F,R,W 
 
_ 
  
 
TC154564  L,R 
 
_ 
  
 
TC155175  L,F,R,W 
 
_ 
  
 
TC162422 L 
 
_ 
  
 
TC163159 L,W 
 
_ 
  
 
TC164523 L 
 
_ 
  
 
TC164665 L,F,R 
 
_ 
  
 
TC166013 Proembryo 
 
_ 
  
 
TC166795 L,F,R CysP10 361      
a
L, leaf; F, flower; R, root; W, whole plant, BY-2, Nicotiana tabacum cv. Bright Yellow 
cell line; 
b
AA, amino acid; -, partial CysP sequences
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Table 3.2 Comparison of published tobacco CysP sequences with tentative contig 
sequences from tobacco EST database. 
CysP 
genes 
Accession # 
Closest tentative  
contiga 
Amino Acid 
identity (%) 
Reference 
NtCP1 AY881011 TC133645 (CysP4) 94.84 (Beyene et al., 2006) 
NtCP2 AY881010.1 TC124565 (CysP2) 96.6 (Beyene et al., 2006) 
CyP7 Z13959.1 TC131927 97.8 (Linthorst et al., 1993) 
CyP8 Z13964.1 TC131927 97.5 (Linthorst et al., 1993) 
NtCP56 EU429306.1 TC166795 (CysP10) 99.17 (Zhang et al., 2009) 
 
a
highlighted tentative contigs, candidate CysPs 
  
35 
 
3.2. Catalytic triad and non-contigious ERFNIN motif are conserved in candidate 
CysPs 
CysP1- CysP8 and CysP10 have a common papain domain that has been shown to be 
responsible for endo and exo-peptidase activity of CysPs. Proteins containing such 
domains are classified under the papain or peptidase_C1 family and are synthesized as 
precursor CysPs (Wiederanders et al., 2003) .  
Precursor CysPs have an additional propeptide sequence preceeding their papain 
domain. As shown in Figure 3.1, all of these CysPs have a propeptide sequence which is 
also called as I29 or the cathepsin propeptide inhibitor domain. For enzyme activation, 
papain family CysPs require a cleavage of the propeptide sequence (Wiederanders et al., 
2003). CysP6 and CysP8 have an additional granulin-like repeat that is known to play a 
role in targeting and activity regulation of certain CysPs (Tolkatchev et al., 2001). CysP9 
may belong to the otubain or peptidase_C65 family since it consists of a single large 
Ovarian Tumor (OTU) domain, and may have similar functions to that of 
deubiquitinating enzymes of the peptidase_C65 family. Detailed information regarding 
putative domain lengths of all candidate CysPs is shown in detail in Table 3.3.  
To identify catalytic residues in the CysPs, the deduced amino acid sequences of 
those belonging to the papain family were aligned, along with a previously characterized 
tobacco CysP, NtCP23 (Figure 3.2). A catalytic triad comprised of Cys25, His159 and 
Asn175 (papain numbering) was found in the papain domain of all aligned CysPs. The 
catalytic site of these CysPs is a thiolate-imidazolium ion pair between Cys25 and 
His159, which forms a reactive cysteine nucleophile (Grzonka et al., 2001). The 
alignment shown in Figure 3.2 excludes CysP3 as it lacked several N-terminal amino acid 
residues, and critical residues Asn and His in the catalytic triad. A highly conserved block 
of amino acid interspersed with variable residues, EX3RX3FX2NX3I/VX3N (ERFNIN 
motif), is present in the propeptide region of all papain family CysPs (Karrer et al., 1993). 
The candidate sequence alignment also revealed such general features in the papain 
family CysPs (Figure 3.2).     
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Figure 3.1: Schematic representation of different domains in papain family tobacco 
CysPs. Candidate CysPs having specific domain types are indicated on the right side. The 
diagram is not drawn to scale. I29, cathepsin propeptide inhibitor domain; Peptidase_C1, 
papain family domain; GRN, granulin like repeats; Peptidase_C65, otubain family 
domain 
  
CysP1, CysP2, CysP4, 
Cysp5, CysP6, CysP7, 
CysP8, CysP10 
CysP6, CysP8 
CysP9 
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Table 3.3 Detail domain information of the candidate CysPs. 
Candidate CysPs 
Cathepsin 
propeptide 
inhibitor domain 
Papain family 
CysP domain 
Granulin 
like 
repeats 
 
Otubain 
domain  
CysP1(NtCP23) 61-117 143-358 X X 
CysP2 Cleaved 5-221 X X 
CysP3 53-110 141-246* X X 
CysP4 42-99 131-348 X X 
CysP5 61-117 143-358 X X 
CysP6(NtCP6) 50-107 138-353 387-435 X 
CysP7 49-105 137-352 X X 
CysP8 1-41 75-292 339-387 X 
CysP9 X X X 45-300 
CysP10 38-93 126-342 X X 
Numbers in the domains represent amino acids.  
*complete coding region sequence was not available. 
X, absent in respective CysPs. 
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CysP2   -----------------------------------------------------------------------------------------   
CysP10  ------------------MKKLLLLLFALALVLRLGES-----FDFHEKELETEEKLWELYERWRSHH-TVSRSLDEKDKRFNVFKANV  65   
CysP7   ------------MAIFSISKLSLLVLFSISLLACTSFARDHSIVGYSSDDLTCIDKLINLFEHWMDKHGKIYKSIEEKLHRFEIFKDNL  77 
CysP4   ------------MAFANLSQYLCLALFFIFLGVWRSQV-------ASSRPINYEASMRARHDQWIAHHDKVYKDLNEKEMRFKIFKENV  70 
CysP8   -------------------------------------------------------------------------------MRLEKFRRNV  10 
NtCP6   --------MATLSFTLTIS---LLLLLFLFFSTLSSASDMSILTYDENQHFRTDDEVMSLYESWLVEHGKSYNALDEKDKRFQIFKENL  78 
NtCP23  MSRFSLLLALVVAGGLFASALAGPATFADENPIRQVVSDGLHELENAILQVVGKTRHALSFARFAHRYGKRYESVEEIKQRFEVFLDNL  89 
CysP5   MSRFTLLLALVVAGGLFAAALAGPATFAVENPIRQVVSDGLHELENGILQVVGQSRHALSFVRFAHRYGKRYESVEEIKQRFEVFLDNL  89 
                                                                                                      
                                                                                             * *                                                                    
CysP2   ----------------------------------------------------------- MRIDVPPTVDWRKKGAVTPVKDQGKCGSC  29 
CysP10  HYVHNFNK---KDKPYKLKLNKFADMTNHEFRHHYAG-SKIKHHRTFLGASRANGTFMYAHEDSVPPTVDWRKKGAVTPVKDQGKCGSC  150 
CysP7   KHIDETNK---IVSNYWLGLNEFADLSHDEFKKMYLG-LKVDN-ELLNKREKSQQEFAYRDFVDLPKSVDWRKKGAVTPVKNQGQCGSC  161 
CysP4   ERIEAFNAG--EDKGYKLGVNKFSDLTNEKFRVLHTG-YKRSHPKVMSS-SKPKTHFRYANVTDIPPTMDWRKKGAVTPIKDQKECGCC  155 
CysP8   KYIVEKNSKRKSDSDHLVGLTNFADMSNEEFRQVHTSKIKIPFDKRKTIQMKNAEKKPTPVYCDAPPSRDWRKHGAVTEVKNQHLCGAC  99   
NtCP6   RYIDEQNS--VPNKSYKLGLTKFADLTNEEYRSMYLG-TKTSDRRRLLK--NKSDRYLPKVGDSLPDSVDWREKGVLVGVKDQGSCGSC  162 
NtCP23  KMIRSHNK---KGLSYKLGVNEFTDLTWDEFRRDRLG--------AAQNCSATTKGNLKVTNVVLPETKDWREAGIVSPVKNQGKCGSC  167 
CysP5   KMIRSHNK---KGLSYKLGVNEFTDLTWDEFRRDRLG--------AAQNCSATTKGNVKLTNAVLPETKDWREDGIVSPVKNQGKCGSC  167 
 
                                      *                                           
CysP2   WAFSTVVAVEGINQIKTNELVSLSEQELVDCDTS-QNQGCNGGLMDMAFEFIKKKGGINTEENYPYMAEGGECDIQKRNSPVVSIDGHE  117   
CysP10  WAFSTVVAVEGTNQIKTNELVPLSEQELVDCDTS-QNQGCNGGLMDMAFEFIKKKGGINTEENYPYMAEGGECDIQKRNSPVVSIDGHE  238 
CysP7   WAFSTVAAVEGINQIKTGNLTSLSEQELIDCDTT-YNNGCNGGLMDYAFQFIISNGGLHKEDDYPYLMEEGTCDEKRDESEVVTIDGYH  249 
CysP4   WAFSAVAATEGLHQLKTGKLIPLSEQELVDCDVEGEDEGCSGGLLDTAFDFILKNKGLTTEANYPYKGEDGVCNKKKSALSAAKIAGYE  244 
CysP8   WAFSACGAMEGINAIVTGEIISLSVQQLINCDNS-TNLGCYGGYMDPAFEWVMNNSGIDSDSDYPYTVSQGACNITKVNQKVVTIDGYR  187 
NtCP6   WAFSAIASVEAVNSIVTGDVISLSEQELVDCDTS-YNDGCNGGLMDYAFDFIIKNGGIDTEEDYPYTGRDGRCDQSRKNAKVVTINGYE  250 
NtCP23  WTFSTTGALEAAYSQAFGKGISLSEQQLVDCAGAFNNFGCNGGLPSQAFEYIKSNGGLDTEEAYPYTGKNGLCKFSSENVGVKVIDSVN  256 
CysP5   WTFSTTGALEAAYSQAFGKGISLSEQQLVDCAGAFNNFGCNGGLPSQAFEYIKSNGGLDTEEAYPYTGKNGLCKFSSENVGVKVIDSVN  256 
 
                                                  *      *                
CysP2   DVPPNDEGSLLKAVANQPVSVAIQASGSDFQFYSEGVFTG-DCGT---ELDHGVAIVGYGTTLDRTKYWIVKNSWGPEWGEKGYIRMQR  202 
CysP10  DVPPNDEGSLLKAVANQPVSVAIQASGSDFQFYSEGVFTG-DCGT---ELDHGVAIVGYGTTLDRTKYWIVRNSWGPEWGEKGYIRMQR  323 
CysP7   DVPANDEQSLLKALANQPLSVAIEASGRDFQFYSGGVFDG-HCGT---ELDHGVAAVGYGTTKG-ADYIIVKNSWGPKWGEKGFIRMKR  333 
CysP4   DVPANSEKALLQAVANQPVSVAIDGSSFDFQFYSSGVFSG-SCST---WLNHAVTAVGYGATTDGTKYWIIKNSWGSKWGDSGYMRIKR  329 
CysP8   DVP-QEESALLCAVAQQPVSAGIDGASADFQLYRGGIYDG-SCSSNPDDLSHGVLIVGYGSAGD-DDYWIIKNSWGTSWGMEGYGYIRR  273 
NtCP6   DVPENNEKALQKAVASQPVSIAIEAGGKDFQHYVSGIFTG-KCGT---AVDHGVVAVGYGSENG-MDYWIIRNSWGASWGEKGYLRVQR  334 
NtCP23  ITLGAEDELKYAVALVRPVSIAFEVIKG-FKQYKSGVYTSTECGNTPMDVNHAVLAVGYGVENG-VPYWLIKNSWGADWGDNGYFKMEM  343 
CysP5   ITLGAEDELKYAVALVRPVSIAFEVIKG-FKQYKSGVYSSTECGNTPMDVNHAVLAVGYGVENG-VPYWLIKNSWGADWGDDGYFKMEM  343 
 
 
CysP2   EIDAEEGLCGIAMQPSYPIKTSSSNPTGSPATAPKDEL---------------------------------------------------  240 
CysP10  EIDAEEGLCGIAMQPSYPIKTSSSNPTGSPATAPKDEL---------------------------------------------------  361 
CysP7   NTGKAEGKCGINKMVSFPVKKK-------------------------------------------------------------------  355 
CysP4   DVHEKEGLCGLAMDASYPTA---------------------------------------------------------------------  349 
CysP8   NTDLPYGVCAINSLASYPTKELASAPSPYPSPAVPPPPSPSPPPPQPPSPKPSECGNLYYCPEDQTCCCELEFFGICVIQSCCPHKNGV  362 
NtCP6   NVASSKGLCGLAIEPSYPVKTGVNPPKPSPSPPSPIKP-------------PTQCDDYAQCPEGTTCCCVFEYYNSCFSWGCCPLEGAT  410 
NtCP23  GKN----MCGIATCASYPVVA--------------------------------------------------------------------  360 
CysP5   GKN----MCGIATCASYPVVA--------------------------------------------------------------------  360 
 
Figure 3.2: Multiple sequence alignment of papain family CysPs. Predicted amino 
acid sequences of NtCP23 (CysP1), CysP2, CysP4, CysP5, NtCP6 (CysP6), CysP7, 
CysP8 and CysP10 were aligned using CLUSTALW and shaded using BOXSHADE 
3.21. Identical and conserved amino acids are shaded in dark and light grey, respectively. 
(*) indicates catalytic residues cysteine (C), histidine (H) and asparagine (N). (*) 
indicates the disulfide bridge-forming cysteine residues. Red box indicate endoplasmic 
reticulum retention signal KDEL in CysP2 and CysP10. The conserved ERFNIN motif in 
the propeptide region is double-underlined. 
* 
* 
39 
 
3.3 Generation of candidate CysP RNAi constructs 
To identify CysPs that influence IL-10 accumulation in tobacco, RNAi silencing of 
selected CysPs was performed. Candidate genes CysP1 to CysP5 were cloned into RNAi 
vector, pK7GWIWG2D(II),0  and CysP6 to CysP10 in pB7GWIWG(II),0  as described in 
section 2.4.1 and Figure 2.2A. Gene specific unique sequences were cloned in opposite 
orientation in the destination vector to create RNAi constructs. The RNAi constructs are 
transcribed to the hairpin RNA precursors which are processed into the small interfering 
RNA’s (siRNA) by the homologues of the enzyme dicer and incorporated into RNA-
induced silencing complex (RISC). Silencing is achieved either by sequence specific 
degradation of complementary target sequences or by repression of CysP messenger 
RNA by the RISC (Meister and Tuschl, 2004). 
Unique regions were identified for each of the CysP sequences to facilitate targeted 
gene silencing. RNAi vectors with the specific CysP inserts were screened using two 
different primer combinations by PCR, which gave the amplicons of different sizes as 
shown in Figure 3.3. The first amplicon was produced by the gene specific CysP forward 
primer (CysPF) and Cmr forward primer (CmrF), and contained the larger intron (In-1, 
376 bp) region. The second amplicon was produced by CysPF and the Cmr reverse 
primer (CmrR), and contained the smaller intron (In-2, 275 bp) region. The silencing 
constructs were transformed into Agrobacterium in-order to deliver them into tobacco 
leaf epidermal cells.                 
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Figure 3.3: Strategy for CysP silencing. Screening of CysP double inserts in the 
silencing vector. Primer combinations used for screening are shown by arrowheads in the 
RNAi construct. Gene specific forward primers (CysPF) and chloramphenicol resistance 
forward and reverse primers (CmrF and CmrR) produce the CysP amplicons of specific 
sizes. Agarose gel images demonstrate the amplicon size differences for specific CysP 
inserts. The numbers on the top of each lane correspond to the amplicon size. 
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 3.4 RNAi silencing of candidate CysP genes and generation of stable CysP silenced 
tobacco lines 
To generate CysP silenced tobacco lines, Agrobacterium cultures harbouring CysP 
RNAi constructs were used to transform tobacco G7 line. The G7 line is a useful control 
for this experiment as in the untransformed state it constitutively overexpresses IL-10. 
Figure 3.4 describes the process of generating CysP silenced tobacco plants using leaf 
disc transformation and the approximate time it required to proceed from one stage to the 
other. The leaf disc and Agrobacterium were co-cultured for 2-3 days and transferred to 
callus induction medium containing herbicide BASTA for selection. After nearly 1.5 
weeks, calli were induced from the transformed tobacco cells, leaving the untransformed 
cells dead in the tissue culture medium. The induced calli were transferred to the 
differentiation medium where they gave rise to small shoots in 4-6 weeks. A single shoot 
was cut from individual callus and transferred to a new plate which later giving rise to an 
independent transgenic line. In approximately 16 weeks from the initial transformation, 
the independent transgenic lines were ready for an evaluation of CysP transcript and IL-
10 levels.    
In addition to the targeted silencing of specific candidate CysPs, a conserved region 
of CysP1 to CysP5 genes was also chosen for silencing and two silenced lines (CysPAll-
Si) were generated. A total of 82 CysP silenced T0 lines were generated for all candidate 
genes (Table 3.4). Since no RNAi line could be generated for CysP5, further work on that 
candidate gene was not carried out. 
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                    L-10 Control                                                    16 weeks: T0 plants in greenhouse 
                                                                                               
Day 1: Co-culture               
              9 weeks: root induction  
                                                                                                    
1.5 weeks: callus induction       4 weeks: callus differentiation  6 weeks: CysP silenced 
tobacco plantlets 
Figure 3.4: Generation of stable CysP silenced tobacco lines. G7 tobacco lines 
overexpressing IL-10 protein were grown in magenta boxes. Leaf discs were cut and co-
cultured with Agrobacterium cultures containing candidate CysP silencing constructs. 
Calli were regenerated from transformed cells and subcultured in differentiation medium 
containing BASTA (4 mg/L). Independent CysP silenced transgenic lines were obtained 
from the individual callus and transferred to the rooting media before transferring them to 
greenhouse.                                                                      
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Table 3.4: Numbers of independent CysP silenced T0 tobacco lines. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                  
                                                                                                   
  
Candidate CysP 
gene 
CysP silenced 
lines (T0) 
Candidate CysP 
gene 
CysP silenced 
lines (T0) 
CysP1 11 CysP6 16 
CysP2 6 CysP7 9 
CysP3 8 CysP8 9 
CysP4 5 CysP9 12 
CysPAll-Si 2 CysP10 4 
 
44 
 
3.5 Silencing of CysP6 increases IL-10 accumulation in independent T0 tobacco lines 
To determine the effect of CysP silencing in the accumulation of recombinant IL-
10, the IL-10 levels were measured using a double sandwich (dsELISA) in T0 tobacco 
lines, all of which were generated from the independent transformation events. The 
principle of dsELISA is shown in Figure 3.5. The dsELISA results revealed that IL-10 
levels were higher in six out of thirteen CysP6 silenced lines compared to the controls 
(Figure 3.6). Three other lines measured for IL-10 (CysP6Si-4, 7 and 13) displayed 
almost similar levels of IL-10 accumulation in comparison to the control. IL-10 level was 
increased by nearly 1.6- fold in CysP6Si-15, the highest IL-10 accumulating line. Results 
indicate that silencing of CysP6 can affect IL-10 accumulation in T0 lines of G7 tobacco. 
IL-10 accumulation levels were also checked for CysP1, CysP2, CysP3, CysP4, 
CysP7, CysP8, CysP9 and CysP10 silenced independent T0 lines. As shown in Figure 3.7, 
there was no increase in IL-10 accumulation among any of these lines when compared to 
the levels in IL-10 control plants except, for CysP8 silenced line (CysP8Si-3). These 
CysP silenced lines were generated over different periods of time. Therefore, for an 
appropriate comparison between the IL-10 levels, IL-10 control plants were also grown at 
the same time with CysP silenced plants. The accumulation of IL-10 varied among the 
control plants, even though the plants were grown under similar conditions. Thus, IL-10 
accumulations for different T0 lines are represented as normalized fold levels. The 
normalized fold levels are the ratios of IL-10 levels present in the silenced lines to the 
levels present in the IL-10 control plants.  
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Figure 3.5: Detection of IL-10 by dsELISA. A) Schematic illustration of IL-10 
quantification. The 96-well ELISA plate was coated with anti- IL-10 capture antibody 
and 0- 2 ng/ml of IL-10 standard was added. Primary and secondary antibodies were 
added allowing triplicate determination to be made in each channel. B) Standard curve 
for the IL-10 concentration versus luminescence intensity (OD405). Luminescence 
increased in concentration dependent fashion.   
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Figure 3.6: IL-10 accumulation in CysP6 silenced T0 tobacco lines. Measurement of 
IL-10 level in independent T0 CysP6 silenced lines by dsELISA. Data label above the bar 
represents IL-10 level of individual CysP6 silenced lines expressed as ng/mg of total 
soluble protein. + indicates the CysP6 silenced lines with higher level of IL-10 
accumulation in comparison to the IL-10 control. TSP, total soluble protein; Si, silenced 
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Figure 3.7: IL-10 accumulation in CysP silenced T0 tobacco lines. IL-10 accumulation 
remains lower in comparison to the controls in T0 generation of CysP1-CysP10 (except 
CysP6) silenced lines. Y-axis represents the normalized value of IL-10/TSP for different 
independent transgenic lines grown at different time period. Blue, red, black and green 
bars are normalized against their respective colour coded IL-10 level in IL-10 control 
plant. Numbers above the bar represent actual IL-10 level in ng/mg of total soluble 
protein in control plants. Si, silenced 
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3.6 IL-10 accumulation increases with plant maturity in tobacco 
To evaluate if the degree of plant maturity affects the production of recombinant 
protein, IL-10 levels in CysP6 silenced lines and IL-10 controls were checked at two 
different time points. The plants were grown simultaneously in the greenhouse and IL-10 
ELISA was done at 4 weeks and 7 weeks after transfer to the greenhouse. The plants 
were approximately 0.5 ft. tall at 4 weeks of age and approximately 1.5 ft. tall at 7 weeks 
of age. As shown in Figure 3.8, the levels of IL-10 accumulation in the leaf tissue 
increased as plants progressed to maturity in both CysP6 silenced and IL-10 control 
plants. Based on this result, to maintain a consistency in experimental approaches, further 
experiments were performed using 7 week-old plants. Moreover, no abnormal growth or 
any morphological differences were observed for the CysP silenced lines compared to IL-
10 controls.    
3.7 Transient silencing of CysP6 increases IL-10 accumulation 
To further examine the effect of CysP6 silencing on IL-10 accumulation levels, 
transient expression experiments were performed in tobacco, and transcript and protein 
accumulation were studied. CysP6 silencing or vector-only (control) constructs were 
transiently delivered to a total of seven, 1.5 ft. tall IL-10 control plants using agro-
infiltration of leaf tissue (Figure 3.9A). After 4 days post infiltration, tissues were 
collected for both protein and transcript analysis. Unlike in vector-only plants where the 
CysP6 transcript was detected by RT-PCR, the CysP6 transcript was undetectable in all 7 
biological replicates infiltrated with the silencing construct (Figure 3.9B). This suggests 
that CysP6 was efficiently silenced by transient infiltration of the silencing construct. The 
same CysP6 silencing construct was used for the generation of stable CysP6 silenced 
transgenic tobacco lines as mentioned previously in section 3.5. 
To check if IL-10 accumulation changed in response to decreased CysP6 transcript, 
IL-10 levels were measured in leaf tissue collected at the same time along with tissue that 
was used for RT-PCR.  
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Fig 3.8: IL-10 accumulation in tobacco plants of different ages. A) A photograph 
showing 7 weeks old CysP silenced tobacco plants in the greenhouse. B) IL-10 
accumulation in 4 weeks and 7 weeks old CysP6 silenced tobacco lines. IL-10 
accumulation increased consistently in CysP6 silenced lines and IL-10 controls over time. 
The numbers indicate different independent CysP6 silenced lines. TSP, total soluble 
protein; Si, silenced. 
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Fig 3.9: Transient silencing of CysP6 in G7 tobacco.  A) 7 Week-old G7 tobacco used 
for transient CysP6 silencing experiment. Leaves (4
th
, 5
th
 and 6
th
 from the top) were 
infiltrated and tissue was used to determine CysP6 transcript and IL-10 accumulation. B) 
CysP6 expression in CysP6 silencing and vector-only (Si Vec.) infiltrated tissue, 4 days 
post infection. The top panel corresponds to Actin (accession no., #AB158612.1) as a 
reference gene and the bottom panel corresponds to CysP6 transcript in the biological 
replicates (1 to 7). C) IL-10 accumulation levels in CysP6 silencing and vector-only 
infiltrated tissues. Numbers on the X-axis represent the biological replicates. D) Change 
in IL-10 accumulation due to transient CysP6 silencing. The IL-10/TSP values are the 
averages of 7 biological replicates and asterisk (*) represents a significant difference in 
IL-10 levels between CysP6-Si and control tissues using student t-test at 95% confidence 
level. Si, Silenced; Vec., Vector. 
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IL-10 levels were found to be higher in all seven biological replicates which were 
infiltrated with the silencing construct, whereas tissue infiltrated with the vector-only 
control accumulated lower levels of IL-10 (Figures 3.9C). The difference in IL-10 
accumulation between CysP6 silenced and control tissues was found to be statistically 
significant (Figure 3.9D). These results also indicate that reduction in CysP6 expression 
results in increased IL-10 accumulation.          
3.8 Transient overexpression of CysP6 does not reduce IL-10 accumulation 
Since silencing of CysP6 increased IL-10 accumulation in both stable and 
transient expression systems, overexpression of CysP6 was carried out to see if it would 
reduce IL-10 accumulation. IL-10 control plants were transiently infiltrated with CysP6 
over-expression or vector-only constructs and IL-10 level was determined 4 days post 
infiltration.  
As shown in Figure 3.10, it was found that IL-10 accumulation in CysP6 
overexpressed tissue was not lower in comparison to the control. Even though a slight 
reduction in the levels of IL-10 was observed for CysP6 overexpressed tissues, the 
difference was not significant.   
In the previous experiment with T0 stable lines, IL-10 accumulation in CysP 
silenced plants (except for CysP6-Si, lines) was either unaffected or in some cases lower 
than in IL-10 controls (Figure 3.7). To check if overexpressing these CysPs could affect 
IL-10 accumulation, full length CysP genes (CysP1, CysP2 and CysP5) were successfully 
cloned and transiently overexpressed in IL-10 control plants. Similar methodologies and 
conditions were followed as in the transient silencing experiment (section 3.7). 
Transiently overexpressing these CysPs did not change IL-10 accumulation, as no 
significant difference was observed between IL-10 levels in the overexpression or vector-
only infiltrated tissues (Figure 3.10).   
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Figure 3.10: Transient overexpression of CysPs in G7 tobacco. A) Schemetic 
representation of  overexpression vector with or without CysP gene. Open reading frames 
of CysP1, CysP2, CysP5 and CysP6 were cloned into expression vector, pB7WG2D,1. B) 
IL-10 level in CysP overexpression (CysP-OE) and vector-only (OE Vec.) samples. 
Agrobacterium containing specific CysP expression constructs were infiltrated in G7 
tobacco plant and IL-10 level was measured 4 days post infiltration. Data labels above the 
bar represent IL-10 accumulation levels. The data were the averages of two biological 
replicates for each construct. OE, overexpression; Vec. vector.  
53 
 
3.9 CysP6 localizes in the ER 
To sufficiently produce IL-10 in tobacco, the protein was targeted to the secretory 
pathway and retained within the ER. To study the possibility IL-10 being degraded by 
CysP6 using the secretory pathway, the intracellular localization of CysP6 was 
performed.  
A translational fusion of CysP6 and YFP was created and transiently expressed in 
N. benthamiana using the methods described in the section 2.5. Protein accumulation was 
monitored via confocal microscopy. Confocal microscopy is an optical imaging 
technique, which with the help of fluorescent probes, enables visualization of  the 
intracellular structures and processes occuring inside the cells. Several net-like structures 
were seen in CysP6-YFP that resembled the localization pattern for the ER (Figure 
3.11A). To confirm if the fluorescence in net-like structures was indeed ER, co-
localization of CysP6-YFP fusion protein with ER localizing control (ER-CFP) was 
performed. ER-CFP construct contained both ER targeting at the N-terminal and 
retention signal sequences (KDEL) fused to the Cterminal end of CFP. Co-expression of 
CysP6-YFP and ER-CFP showed overlap of CFP signal with that of YFP from CysP6-
YFP (Figure 3.11B), thus confirming that CysP6 localizes in the ER in tobacco leaf cells. 
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Figure 3.11: ER localization of CysP6. A) Agrobacterium tumefaciens carrying 
pCysP6-YFP and pER-CFP plasmids were infiltrated into N. benthamiana  and visualized 
using confocal microscopy. ER localization of CysP6-YFP is seen in tobacco leaf cells. 
White box indicates the region with network like structures. B) Co-expression of CysP6-
YFP and ER-CFP showing the overlapping of YFP and CFP signals. SP, signal peptide, 
Scale bars indicate15 µm. Images shown in A and B are the representatives. 
pEG101-CysP6-YFP 
 
pEG101-ERCFP 
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3.10 Generation of CysP silenced T1 tobacco lines 
From the ELISA analyses of T0 plants it had been found that silencing of CysP6 
increases IL-10 accumulation. Moreover, silencing of other candidate CysPs lowers or 
doesn’t affect IL-10 levels in the T0 plants. To study if the effect of CysP silencing on IL-
10 accumulation can be stable over generations, T1 plants were generated using seeds 
obtained from the T0 CysP silenced plants. As plants segregate for transgenes in 
successive generations, seeds from CysP6-CysP10 silenced T0 lines were screened in 
BASTA containing medium and genotyping was done to confirm the presence of 
transgene in T1 plants (Figure 3.12A and 3.12C). For seeds from CysP1-CysP5 silenced 
lines, since the transgenic plants inherit eGFP from the RNAi vector (see 2.4.1 of method 
section), selection was done by observing GFP fluorescence under the UV microscope. 
As shown in Figure 3.12B, a transgenic line is recognized by visualizing green 
fluorescence under the UV.   
The T1 transgenic lines were also confirmed by genotyping (3.12C). Genomic 
DNA was extracted from at least 2 biological replicates of each CysP silenced T1 line and 
primers specific to Cmr gene present in the CysP silencing construct were used for PCR. 
Transgenes were present in a total of 64 T1 lines. The numbers of CysP silenced T1 lines 
generated for each candidate CysP gene is shown in Table 3.5. All the T1 lines were 
grown in the greenhouse and used for IL-10 ELISA analysis when the plants were of 
mature height (nearly 1.5 ft. tall). 
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Figure 3.12: Generation of CysP silenced T1 tobacco lines. A) Screening of T0 seeds 
from CysP silenced tobacco lines. Seeds from CysP6-CysP10 silenced lines were grown 
on MS basal medium supplemented with BASTA. B) Screening of T0 seeds from CysP1-
CysP5 silenced tobacco lines. Seeds were grown in MS basal medium and transgenic 
plants were selected by observing GFP fluorescence (green colour) under UV. Images 
show a CysP silenced transgenic line under white light (W) and UV.  C) Genotyping of 
T1 plants By PCR to validate the presence of Cmr gene. A representative gel image 
showing  amplicon of 520 bp corresponding to Cmr positive lines (contain RNAi 
constructs). Empty lane indicated by the asterisk sign corresponds to a Cmr –ve line 
(doesn’t contain RNAi construct). Positive PCR control, pB7GWIWG2(II),0 plasmid.  
  
      
W UV 
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Table 3.5: Numbers of CysP silenced T1 tobacco lines. 
                 
 
 
 
    
 
  
Candidate 
CysP gene 
CysP silenced 
lines (T1) 
Candidate 
CysP gene 
CysP silenced 
lines (T1) 
 
CysP1 9 CysP6 12  
CysP2 4 CysP7 9  
CysP3 8 CysP8 7  
CysP4 3 CysP9 12  
CysPAll-Si 1 CysP10 -  
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3.11 IL-10 accumulation in CysP silenced T1 tobacco lines 
To study the stability of IL-10 accumulation in the CysP silenced tobacco plants, 
IL-10 levels were measured for a total of 30 different T1 lines. The production of IL-10 
was stable over successive generations of tobacco (Figure 3.13). CysP silenced T1 lines 
(CysP1-Si, CysP2-Si, CysP3-Si, CysP4-Si) all showed lower levels of IL-10 in 
comparison to their respective IL-10 control plants (represented by same color bars in 
Figure 3.13). Lower IL-10 accumulation was also seen for these lines in the T0 generation 
(Figure 3.7). In a similar pattern to that seen in the T0 generation, CysP6 silenced T1 lines 
showed nearly equal (line 2 and 15) or higher (line 8 and 9) levels of IL-10 accumulation 
in comparison to respective control plant. This suggests that, the effect of CysP silencing 
on IL-10 accumulation in tobacco remains similar over the next generation.  
3.12 CysP6 silenced T1 lines display reduced expression of CysP6  
To confirm that the increased IL-10 accumulation in CysP6-Si lines resulted from 
reduced CysP6 levels, transcript abundance was quantitated using qRT-PCR. As shown 
in Figure 3.14, CysP6 expression was lower in all CysP6-Si lines in comparison to the 
IL-10 controls. A comparison of CysP6 silencing and IL-10 accumulation was done 
between CysP6 silenced lines and control and the correlation between silencing of CysP6 
and resulting IL-10 accumulation was studied. CysP6 transcript was higher (IL-10 
control), IL-10 accumulation was lower, and as Cys6 transcript was lower (CysP6Si-9, 
CysP6Si-8), IL-10 accumulation was higher. However, a high error was seen in CysP6 
expression among CysP6Si-9 and CysP6Si-15 lines. Larger numbers of replicates are 
required in-order to relate the degree of CysP6 silencing and accumulation of 
recombinant protein in transgenic plants.     
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Figure 3.13: IL-10 accumulation in CysP silenced T1 tobacco lines. Normalized IL-10 
levels among different CysP-Si T1 lines and controls. Green, blue and yellow colour bars 
are normalized to IL-10 levels in their respective respective control plants (IL-10 control, 
on the right). Numbers above the bar represent actual IL-10 level in ng/mg of total 
soluble protein. Error bars represent the mean of at two biological replicates for all the 
lines except CysP6-Si lines 8 and 15 (3 biological replicates).   
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Figure 3.14: CysP6 expression and IL-10 accumulation in CysP6 silenced T1 lines. A 
comparison between IL-10 accumulation and CysP6 expression levels of CysP6 silenced 
lines and controls. Blue bars represent IL-10/TSP normalized to IL-10 control and orange 
bars represent fold expression of CysP6 normalized to Actin. Three biological replicates 
were used for all the lines and control except for lines 2 and 9 (2 biological replicates). 
Error bars represents the standard deviation.      
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 Chapter 4: Discussion 
CysPs are known to be the major proteases that affect the total yields of 
recombinant proteins in plants. However, none of the CysPs that are implicated in the 
regulation of recombinant protein accumulation have been reported so far in tobacco, 
despite the fact that tobacco is an ideal platform for protein production. In this study, the 
role of tobacco CysPs in regulating recombinant IL-10 accumulation in transgenic 
tobacco was investigated. The results obtained are discussed below. 
4.1 Identification of CysPs involved in IL-10 proteolysis 
  To identify CysPs that potentially alter IL-10 accumulation in tobacco, all the 
expressed CysPs were identified by searching the TGI database. Since the tobacco 
genome sequence has not been published yet, the TGI database is the only major source 
of information regarding gene sequences and their tissue specific expression. At least 60 
putative CysPs were identified in tobacco (Table 3.1 and Table 3.2). The total number of 
CysPs may change as more ESTs are deposited in the database or after the availability of 
whole genome sequence of tobacco. Out of 32 tentative contig sequences available for 
CysPs, 9 contained full open reading frame.  
The CysP gene family in tobacco appears to be a large gene family, and is 
comparable to that of other plants such as Arabidopsis (38 CysP genes) and Populus (44 
CysP genes) (Garcia-Lorenzo et al., 2006). Evolutionarily, tobacco (N. tabacum) 
originated from an interspecific cross of two wild forms, N. sylvestris and N. 
tomentosiformis. The interspecific cross between two diploid species with equal number 
of chromosomes (12 pairs each) resulted into a fertile amphiploid carrying a total of 24 
pairs of chromosomes (Leitch et al., 2008). The larger number of CysPs in tobacco could 
have resulted from the preservation of CysPs from both of the parents. Many of these 
CysPs may have critical roles in normal plant growth and development and responses to 
biotic and abiotic factors that have been characterized in many plant species including 
tobacco  (Grudkowska and Zagdanska, 2004). CysPs are known to initiate and mediate 
storage protein degradation in germinating cereal seeds (Kato and Minamikawa, 1996). 
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For example, rice REP-1 digests the rice seed storage protein glutein in vitro, and is 
regulated by giberellic acid in germinating seeds (Ho et al., 2000). The expression of 
tobacco the CysP, NtCP23, was enhanced during senescence and is similar to what is 
seen in other plant senescence associated CysPs and mammalian Cathepsin H (Ueda et 
al., 2000). Degradation of proteins during senescence is essential for amino acid 
remobilization. Similarly, CysPs have been implicated in cold, drought and wounding 
stress  (Schaffer and Fischer, 1988; Koizumi et al., 1993; Linthorst et al., 1993) , as well 
as during programmed cell death (Ling et al., 2003; Zhao et al., 2013).  
Out of 55 putative CysPs identified in the EST database, CysP1-CysP10 were 
selected for characterization because they were known to be expressed in leaves and had 
a complete sequence availability in the EST database. These CysPs were of primary 
interest as they may target IL-10 expressed in the tobacco leaves. As shown in Table 3.1, 
41 out of 55 putative CysPs were found to be expressed in leaf, which was considered as 
either in leaf only or seedling or in pooled sample of leaf, flower and root tissues. Eight 
out of these 41 (CysP1, CysP2, CysP4, CysP5, CysP6, CysP7, CysP8 and CysP10) 
consisted of complete open reading frames and their putative protein sequences contained 
peptidase_C1 domain (Figure 3.1). Peptidase_C1 is also called papain domain, as the 
name is given to all the CysPs containing Cys, His and Asn amino acid residues in their 
catalytic triad and was first characterized in Papaya proteinase 1 from Carica papaya 
(Grzonka et al., 2001). Many papain family CysPs have been characterized in plants and 
animals that are known to degrade indigenous and foreign proteins (Shenai et al., 2000; 
Outchkourov et al., 2003).  
The papain family tobacco CysPs consist of 38-250 long propeptide sequence and 
are possibly synthesized as precursor CysPs (Grudkowska and Zagdanska, 2004) (Figure 
3.1 and Table 3.3). Their papain domain comprised 220-260 amino acids and might 
represent the mature enzyme. Activation of papain CysPs is effected by intra- or inter-
molecular proteolysis, where the propeptide sequence is cleaved off (Wiederanders et al., 
2003). CysP6 and CysP8 contain an extra GRN motif, the role of which in plant is not 
well understood, but is implicated in protein-protein interactions, targeting and/or activity 
regulation inside the cell (Tolkatchev et al., 2001). In Arabidopsis, GRN is removed by 
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autocatalysis in RD21, a CysP involved in plant immunity and senescence. However, in 
an in vitro condition, removal of GRN is not necessarily required for enzyme activation 
(Gu et al., 2012). 
CysP9 is an otubain CysP. CysP9 is predicted to contain a large OTU domain, and 
Asp, Cys and His residues in its putative catalytic triad. Proteins containing such domain 
are classified as deubiquitinating enzymes, and have been shown to play a role in 
removing ubiquitin from the proteins that are bound for degradation in proteasome-
ubiquitin pathway (Balakirev et al., 2003), suggesting a similar role for CysP9 in tobacco.  
 As shown in Table 3.2, five additional full length CysP sequences were identified 
and characterized in tobacco, bringing the total to at least 60 CysPs. These sequences 
were not represented in the TGI database, suggesting the possibility of additional CysPs. 
The release of the whole genome sequence of tobacco will help in the genome-wide 
identification of CysPs genes. These five additional sequences showed a high degree of 
amino acid identity with the TC sequences in the TGI database, and were expressed 
mostly in tobacco leaf tissue. NtCP1 was expressed only in senescing leaf and is likely a 
senescence marker in tobacco plant (Beyene et al., 2006). NtCP2 is a CysP with KDEL 
signal in its C-terminal and was expressed in the mature tobacco leaves (Beyene et al., 
2006). NtCP56 was strongly expressed in anthers and was involved in pollen grain 
development (Zhang et al., 2009). CyP7 and CyP8 were weakly expressed in leaf tissue 
and their transcript accumulation increased by six fold in response to wounding, 
indicating that they are possibly stress related CysPs (Linthorst et al., 1993). A very high 
degree of amino acid identity was found between NtCP56 and CysP10 (99.17%), with 
changes in three amino acid residues (Iso162 to Tyr, Ser172 to Pro, Lys306 to Arg). At 
the nucleotide level, NtCP56 is 98.6% identical to CysP10 with the sequence coverage of 
66.6% of CysP10, suggesting that they are not the same CysPs. However, as NtCP56 and 
CysP10 share very high degree of amino acid identity, it can be speculated that these two 
CysPs are protein isoforms in tobacco. CyP7 and CyP8 showed similarity to TC131927, 
which is surprisingly not included in the list of 55 putative CysPs, but was found as the 
result of BLAST with the TGI database by using the respective nucleotide sequence as 
the query sequence. 
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4.2 ERFNIN motif and catalytic triad is conserved in papain family tobacco CysPs 
Sequence alignment of the papain family candidate CysPs, which also included 
two previously characterized NtCP6 and NtCP23, showed a conserved ERFNIN motif in 
their propeptide sequence (Figure 3.2). The ERFNIN motif is shared by CysPs from 
diverse group of species, ranging from protozoa to mammals, and has been mostly 
reported in mammalian cathepsin H and L type proteins (Karrer et al., 1993). Mammalian 
cathepsins are known to carry out different intracellular and extracellular functions that 
require right balance of enzyme activation from precursor CysPs. Intracellularly, they 
function in apoptosis, antigen and protein processing .Whereas extracellularly, they 
contribute directly to the degradation of foreign proteins and the extracellular matrix 
(Dickinson, 2002). The signature ERFNIN motif is thought to be associated mostly with 
inhibiting protease activity before enzyme activation is required.  
Also seen in the amino acid alignment, a conserved catalytic triad comprising of 
Cys25, His159 and Asn175 residues was found in all the candidate papain family CysPs. 
Enzymatic activity of CysP is dependent on Cys25 and His159 residues, which exist as 
ion-pairs in a pH interval of 3.5-8 (Grzonka et al., 2001). The role of Asn175 in the 
catalytic triad is not understood well, but is thought to be responsible in maintaining 
structural integrity of the enzyme, as it is conserved across all papain family CysPs 
(Vernet et al., 1995). Besides catalytic Cys residue, four other Cys residues were also 
identified to be conserved in the papain domain of all aligned CysPs. These residues are 
likely involved in disulfide bridge formation, thus in proper folding and activity of the 
enzyme.    
4.3 CysP6 is involved in reducing IL-10 accumulation in tobacco 
Quantitative analysis of IL-10 levels in CysP6 silenced tobacco lines showed 
increased accumulation compared to the IL-10 control (Figure 3.6). Some CysP6 silenced 
lines showed no change in IL-10 accumulation while others accumulated lower level of 
IL-10 in comparison to the IL-10 control plant. Thus, the accumulation of recombinant 
protein varied across different CysP6 silenced lines. The variation in the IL-10 levels 
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could have resulted from a position effect or differential levels of CysP6 gene silencing 
(also seen in CysP6 expression levels in different CysP6 silenced T1 lines, Figure 3.14). 
Such a position effect has been explained by researchers in several transgenic plants and 
animals  (Matzke and Matzke, 1998).     
Silencing indigenous tobacco putative CysPs; CysP1, CysP2, CysP3, CysP4, 
CysP5, CysP7, CysP8, CysP9 and CysP10 did not increase IL-10 accumulation (Figure 
3.7). Surprisingly, in all of these CysP silenced T0 independent transgenic lines, the level 
of IL-10 accumulation remained lower in comparison to that of the IL-10 control plant. 
Since silencing these CysPs didn’t result in an increase in IL-10 accumulation, no further 
characterization was done with these respective transgenic lines. However, performing a 
detailed transcript analysis of all candidate CysPs can be done in-order to know if and to 
what extent these CysPs are silenced, and how does silencing relate to IL-10 
accumulation seen in the individual silenced lines. More work is required to reach 
conclusions regarding their role in recombinant protein accumulation in tobacco.       
4.4 IL-10 accumulation in tobacco increases with plant maturity 
Inherent factors affecting synthesis and accumulation of IL-10 have been 
characterized in detail in Arabidopsis (Chen et al., 2013). To study if physical parameters 
such as age and height of the plant affect IL-10 accumulation, IL-10 content was 
measured at two different time points (Figure 3.8). In 7 week-old tobacco, the plants 
accumulated a higher amount of IL-10 in all the transgenic lines in comparison to the 4 
weeks old plants, which suggests that IL-10 production increases with plant maturity. 
For the production of IL-10 in tobacco, the recombinant protein requires 
harvesting before the flowering stage of the plant. Therefore, IL-10 levels in plants older 
than 7 weeks were not determined. Moreover, after flowering the expression of 
senescence associated genes could pose a problem in recombinant protein accumulation, 
as protease activities are high in senescessing organs. Higher protease activity during leaf 
senescence has been reported in many plants including tobacco and CysPs are known to 
be responsible for it (Ueda et al., 2000; Beyene et al., 2006).  
66 
 
To minimize the possible error that can arise due to differences in transgene 
expression between young and mature leaves of the same plant, IL-10 level for each line 
was averaged from fully expanded 4
rd
, 5
th
 and 6
th
 leaves from the top, thus excluding 
variability caused during sampling, if any.  
 4.5 Transient knockdown of CysP6 in tobacco leaf 
Identification of CysP6 as a potential candidate involved in affecting recombinant 
protein accumulation is a first reported case in tobacco. To study further the effects of 
silencing CysP6 on the accumulation of CysP6 transcript and subsequent IL-10 levels in 
tobacco, a transient experiment was performed. Transient expression of the CysP6 RNAi 
construct resulted in near to invisible levels of CysP6 transcript and significantly 
increased the accumulation of IL-10 in tobacco (Figures 3.9B and D). This also 
confirmed the putative role of CysP6 in determining the yield of foreign protein, which 
was also seen in stable silenced lines.  
With the post-genomic era and a flooding of gene sequences, several ways have 
been explored to assign putative gene functions. Because of its efficiency and specificity, 
RNAi is one of the widely used techniques in determining gene function. Most of the 
RNAi approaches utilize generation of stable transgenic lines and observation of RNAi 
phenotypes related to the particular genes. However, generation of stable lines usually 
requires a long time, which may range from 2-6 months depending on the type of plants 
used (4 months in tobacco, see Figure 3.4). Using Agrobacterium-mediated transient 
expression of the silencing construct, gene functions can be determined in a short period 
of time. As seen in this study, transient silencing of CysP6 could be achieved in nearly a 
week, which is very short compared to the time required to generate stable transgenic 
tobacco lines. Transient silencing of indigenous genes via agro-infiltration had been 
reported so far in plant species such as Vitis vinifera (Bertazzon et al., 2012), but not in 
tobacco. Particularly with the results seen here, transient RNAi can be efficiently utilized 
for gene functional assays in tobacco.  
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4.6 CysP6 localizes to the ER 
CysP6 fused to YFP showed that it is localized to the ER. It was interesting to see 
that CysP6 is localized in the ER, without the presence of C-terminal ER retrieval signal 
sequence KDEL or HDEL in its C-terminal end (see Figure 3.2 for CysP6 sequence). 
However, CysP6 consists of a signal peptide with predicted cleavable position between 
26
th 
(Ala) and 27
th 
(Ser) residues in its amino acid sequence.  Localization of the proteins 
with the signal peptide can possibly be in the ER lumen, ER membrane, tonoplast, cell 
membrane or extracellular space and are collectively processed through the secretory 
pathway involving ER as the initial component. Several ER resident proteins that lack the 
retention signal are known to localize in the ER in a signal-independent fashion (Gu et 
al., 2012). Arabidopsis RD21 is one of such protein without KDEL sequence, and is 
localized to the vacuole and ER in response to osmotic stress and wounding (Gu et al., 
2012).  Some of these proteins retained in the ER also play a role in quality control 
through an interaction with the ER chaperones, whose function is to retain and 
subsequently degrade assembly defective proteins (Hammond and Helenius, 1995).  
    Accumulation of proteins targeted to the ER has been reported to be affected by 
plant proteases (Stevens et al., 2000). It was shown that IgG1 targeted to accumulate in 
the ER is possibly degraded by acidic proteases, most of which consisted of senescence 
associated CysPs (Stevens et al., 2000). A study by Sharp and Doran (2001) indicated 
that initiation of the antibody IgG1 degradation in a transgenic tobacco cell suspension 
culture occurs along the secretory pathway outside the ER (Sharp and Doran, 2001). 
Localization of CysP6 to the ER provides greater possibility of its involvement in IL-10 
degradation, since IL-10 accumulates in the ER. The degradation process might be 
occurring along the secretory route when IL-10 is being processed or accumulated. 
However, more study should be conducted regarding the fate of IL-10, to prove the 
speculation that IL-10 degradation occurs along secretory pathway, thus affecting its 
overall yield in tobacco plant.   
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4.7 CysP6 silenced lines show reduced CysP6 expression in T1 generation 
CysP6 expression was measured in four CysP6 silenced T1 lines (2, 8, 9 and 15) 
by qRT-PCR and it was found that the CysP6 transcript level was lower in all four lines 
in comparison to the IL-10 control plant (Figure 3.14). The normalized fold expression of 
CysP6 varied among the lines, suggesting that the degree of CysP6 silencing was 
different in each line. The differential level of silencing is a common character of RNAi-
mediated gene silencing in plants (Kerschen et al., 2004). Multiple genes were silenced in 
Arabidopsis using different RNAi constructs, which showed significant transcript 
variability between the independent RNAi lines of same target gene (Kerschen et al., 
2004). In tobacco, the degree of gene silencing was analyzed in three independent lines 
carrying 35S- β-Glucorinidase (GUS) transgenes, and it was found that the amount of 
antisense GUS RNA co-related with the extent of post-transcriptional silencing in each 
line (Hamilton and Baulcombe, 1999). Differential silencing was also observed in the 
expression of rice CysP (OSEP3A, encodes REP1), as small interfering (si) RNA was 
targeted to silence OSEP3A in transgenic rice cell lines expressing recombinant hGM-
CSF (Kim et al., 2008).  
The expression of siRNA and the silencing of a target gene depend on several 
factors, collectively referred to as the “position effect” (Matzke and Matzke, 1998). Such 
an effect is caused by the telomeric (stable expression) or centromeric (mosaic 
expression) integration of transgenes in the chromosome and transfer of the binary vector 
sequences that reduces transgene expression (Matzke and Matzke, 1998). Differential 
silencing of CysP6 seen in the T1 tobacco plants, which were obtained from the T0 
independent transgenic lines, might also be a result of the position effects.  
A comparison of CysP6 expression and IL-10 accumulations in the CysP6 
silenced T1 lines showed no correlation. In the plants with lower CysP6 expression (line 8 
and 9), IL-10 accumulation was higher in comparison to the controls. Two of the CysP6 
silenced lines showed higher error in expression levels of CysP6 (line 9 and 15), thus 
their relation to corresponding levels of IL-10 is not conclusive. A higher number of 
stable lines and biological replicates should be included to draw a conclusion regarding a 
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correlation, which might exist between the degree of CysP6 silencing and resulting IL-10 
accumulation in tobacco.   
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Chapter 5: Perspectives and Future work 
Plants have emerged as major choice in producing biopharmaceutical proteins. 
High production costs hamper other production systems such as microbial fermentation 
or animal-based systems. Using plants, higher yields and economic production of 
recombinant proteins can be achieved by creating stable transgenic lines that can simply 
be propagated using agriculture.  
Identification of the members of the tobacco CysP family is the first step in 
exploring the potential roles of many CysPs in plant growth and cellular responses to 
environmental stimuli, including foreign protein antigens. With at least 60 putative 
CysPs, the tobacco CysP gene family is possibly one of the largest plant CysP families. 
As plant CysPs are reported to be involved in the degradation of many heterologous 
proteins, it is necessary to understand the role of tobacco CysPs in IL-10 proteolysis. 
Identifying a CysP involved in the degradative process is a major step towards alleviating 
protease effects and improving protein yields in tobacco. Out of 10 candidate CysPs 
chosen for study, CysP6 was found to be potentially involved in IL-10 proteolysis. Stable 
silencing of CysP6 resulted in an increase in IL-10 accumulations over two generations of 
tobacco. The potential link of CysP6 to IL-10 degradation was also established by 
transiently silencing CysP6. Further characterization of CysP6 is necessary to confirm a 
direct role in IL-10 degradation, which can be done by using activity-based protein 
profiling (ABPP) techniques (van der Hoorn et al., 2004; Cravatt et al., 2008). More 
evidences can be generated by doing CysP activity assay and it can help to verify that 
functional protease activity is lower in CysP6 silenced lines in comparison to the IL-10 
control plants. Confirmation of CysP6 roles could open opportunities such as creating 
CysP6 depleted tobacco lines that can be utilized to study the accumulation of other high 
value therapeutic proteins.    
As shown in Figure 3.14, IL-10 accumulation in the T1 generation of CysP6 
silenced lines and a differential CysP6 expression in their respective biological replicates 
indicated the inconclusive correlation between degree of CysP6 silencing and resulting 
IL-10 accumulation. A higher number of stable transgenic lines and biological replicates 
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should be analyzed to study correlation between degree of CysP6 silencing and IL-10 
accumulation. Moreover, even though the silencing construct was targeted to the unique 
region in CysP6, it is reasonable to study if silencing is specific to CysP6 only. The study 
of silencing specificity can be done by a transcript level analysis of all other candidate 
CysPs in the CysP6 silenced lines.  It will be helpful to know if CysPs other than the 
CysP6 have a potential impact in IL-10 accumulation.  
Subcellular localization of CysP6 in the ER, even without presence of an ER 
retention signal, could be due to presence of a signal peptide which directs proteins to the 
secretory pathway and is functionally required to perform roles similar to the ER resident 
proteases. ER resident proteins are involved in degradation of proteins and some of them 
lack an ER retention signal (Gu et al., 2012). Based on CysP6 localization study, it is 
plausible that ER could potentially be the site of IL-10 proteolysis as IL-10 is also 
targeted to accumulate in the ER. To confirm that IL-10 is degraded in the ER, 
subcellular fractioning can be done followed by immunoblotting with anti-IL-10 
antibodies.  
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